http://jnci.oxfordjournals.org/content/89/11/790.full
<!DOCTYPE html
  PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html
      xmlns="http://www.w3.org/1999/xhtml"
      xml:lang="en"
      lang="en">
   <head>
      <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
      <title>Economic Implications of Hepatic Arterial Infusion Chemotherapy in Treatment of Nonresectable Colorectal Liver Metastases
         
      </title>
      <meta name="googlebot" content="NOODP" />
      <meta name="HW.ad-path" content="/cgi/content/full/89/11/790" />
      <meta content="/jnci/89/11/790.atom" name="HW.identifier" />
      <meta name="DC.Format" content="text/html" />
      <meta name="DC.Language" content="en" />
      <meta content="Economic Implications of Hepatic Arterial Infusion Chemotherapy in Treatment of Nonresectable Colorectal Liver Metastases"
            name="DC.Title" />
      <meta content="10.1093/jnci/89.11.790" name="DC.Identifier" />
      <meta content="1997-06-04" name="DC.Date" />
      <meta content="Oxford University Press" name="DC.Publisher" />
      <meta content="Isabelle Durand-Zaleski" name="DC.Contributor" />
      <meta content="Béatrice Roche" name="DC.Contributor" />
      <meta content="Pierre-Louis Fagniez" name="DC.Contributor" />
      <meta content="Jean-Paul Le Bourgeois" name="DC.Contributor" />
      <meta content="Pascal Piedbois" name="DC.Contributor" />
      <meta content="Marc Buyse" name="DC.Contributor" />
      <meta content="Robert Carlson" name="DC.Contributor" />
      <meta content="Michael J. O'Conell" name="DC.Contributor" />
      <meta content="Philippe Rougier" name="DC.Contributor" />
      <meta content="Alfred E. Chang" name="DC.Contributor" />
      <meta content="Vernon K. Sondak" name="DC.Contributor" />
      <meta content="Margaret M. Kemeny" name="DC.Contributor" />
      <meta content="Tim G. Allen-Mersh" name="DC.Contributor" />
      <meta content="Journal of the National Cancer Institute"
            name="citation_journal_title" />
      <meta content="JNCI J Natl Cancer Inst" name="citation_journal_abbrev" />
      <meta content="0027-8874" name="citation_issn" />
      <meta content="1460-2105" name="citation_issn" />
      <meta name="citation_author" content="Isabelle Durand-Zaleski" />
      <meta name="citation_author" content="Béatrice Roche" />
      <meta name="citation_author" content="Pierre-Louis Fagniez" />
      <meta name="citation_author" content="Jean-Paul Le Bourgeois" />
      <meta name="citation_author" content="Pascal Piedbois" />
      <meta name="citation_author" content="Marc Buyse" />
      <meta name="citation_author" content="Robert Carlson" />
      <meta name="citation_author" content="Michael J. O'Conell" />
      <meta name="citation_author" content="Philippe Rougier" />
      <meta name="citation_author" content="Alfred E. Chang" />
      <meta name="citation_author" content="Vernon K. Sondak" />
      <meta name="citation_author" content="Margaret M. Kemeny" />
      <meta name="citation_author" content="Tim G. Allen-Mersh" />
      <meta content="Economic Implications of Hepatic Arterial Infusion Chemotherapy in Treatment of Nonresectable Colorectal Liver Metastases"
            name="citation_title" />
      <meta content="06/04/1997" name="citation_date" />
      <meta content="89" name="citation_volume" />
      <meta content="11" name="citation_issue" />
      <meta content="790" name="citation_firstpage" />
      <meta content="795" name="citation_lastpage" />
      <meta content="89/11/790" name="citation_id" />
      <meta content="89/11/790" name="citation_id_from_sass_path" />
      <meta content="jnci;89/11/790" name="citation_mjid" />
      <meta content="10.1093/jnci/89.11.790" name="citation_doi" />
      <meta content="http://jnci.oxfordjournals.org/content/89/11/790.abstract"
            name="citation_abstract_html_url" />
      <meta content="http://jnci.oxfordjournals.org/content/89/11/790.full"
            name="citation_fulltext_html_url" />
      <meta content="http://jnci.oxfordjournals.org/content/89/11/790.full.pdf"
            name="citation_pdf_url" />
      <meta content="http://jnci.oxfordjournals.org/content/89/11/790"
            name="citation_public_url" />
      <meta content="9182977" name="citation_pmid" />
      <meta name="citation_section" content="Article" />
      <meta name="robots" content="noarchive,nofollow" />
      <meta name="googlebot" content="noarchive" />
      <link href="/content/89/11/783.short" rel="prev" />
      <link href="/content/89/11/796.short" rel="next" />
      <link rel="stylesheet" type="text/css" media="all" href="/shared/css/hw-global.css" />
      <link rel="stylesheet" type="text/css" media="print" href="/shared/css/hw-print.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/local/css/hw-local-global.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/publisher/css/hw-publisher-global.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/publisher/css/hw-publisher-ac.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/hw-page-content.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/jquery.fancybox-1.3.4.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/hw-global-colexpand.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/publisher/css/hw-publisher-page-content.css" /><script type="text/javascript" id="session-d29145130e1">var callbackToken='537A58B668C3005';</script><script type="text/javascript" id="session-d29145130e3">
                      var subCode='oupjournal_sub';
                    </script><script type="text/javascript">
            var gAuthTimeStamp = '2015-10-27T12:16:23.985-07:00';
            var gSessionId = 'uAZN6xL49CPcA9xVwFwBIA';
            var gAuthzRequired = 'false';
            var gAuthnMethods1 = 'ip';
            var gAuthnMethods2 = 'ip';
            var gAuthnIPs = '18.189.59.169';
            var gAuthnIndividuals = '';
            var gAuthnInstitutions = '10005282,10072538,10328193,100274300,10082403,05094000,10093227,153074108,10080507,21879000,10095822,10081742,10082405,10004595,10019502,10082401,07635000,10082404,06602000';
            </script><script type="text/javascript" src="/shared/js/jquery-min.js"></script><script type="text/javascript" src="/shared/js/fingerprint.js"></script><script type="text/javascript" src="/shared/js/hw-shared.js"></script><script type="text/javascript" src="/publisher/js/hw-publisher-site.js"></script><script type="text/javascript" src="/local/js/local-js-vars.js"></script><script type="text/javascript" src="/shared/js/pages/hw-content.js"></script><script type="text/javascript" src="/shared/js/fancybox/jquery.fancybox-1.3.4.js"></script><script type="text/javascript" src="/shared/js/fancybox/jquery.easing-1.3.pack.js"></script><script type="text/javascript"
              src="/shared/js/fancybox/jquery.mousewheel-3.0.4.pack.js"></script><script type="text/javascript" src="/shared/js/util/content.jquery.addVariantLink.js"></script><script type="text/javascript" src="/shared/js/util/hw-col-expand.js"></script><script type="text/javascript" src="/publisher/js/hw-publisher-modalwin-vars.js"></script><script type="text/javascript"
              src="/publisher/js/hw-publisher-article-dynamic-elements.js"></script><script type="text/javascript" src="/publisher/js/hw-publisher-content.js"></script><script type="text/javascript" src="/shared/js/util/hw-mathjax.js"></script><script type="text/x-mathjax-config">
          MathJax.Hub.Config({
              tex2jax: {
                inlineMath: [["$","$"],["\\(","\\)"]],
                processClass: "tex2jax_process|mathjax"
              }
            });
          MathJax.Hub.Queue(function() {
            gColTempResize = true;
            fixColHeights(1);
            gColTempResize = false;
          });
       </script><script type="text/javascript"
              src="http://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script><script type="text/javascript">
	    
	    
	    
	    var siqDOI = encodeURIComponent("10.1093/jnci/89.11.790");
	    var siqIsOpenAccess = encodeURIComponent("");
	    var siqPubDate = encodeURIComponent("19970604");

	    if (siqDOI.length == 0) {
	        siqDOI = "UNKNOWN";
	    }
	    
	    
		
		
	    if (gAuthnIndividuals.length != 0) {
		if (gAuthnInstitutions.length != 0) {
		    authnEntity = encodeURIComponent(gAuthnIndividuals
		        + ',' + gAuthnInstitutions);
		} else {
		    authnEntity = encodeURIComponent(gAuthnIndividuals);
		}
	    } else {
	        authnEntity = encodeURIComponent(gAuthnInstitutions);
	    }

	    var commonString =
		'authSessionId=' + gSessionId + String.fromCharCode(0x26)
		+ 'authzRequired=' + gAuthzRequired + String.fromCharCode(0x26)
		+ 'authentication_method=' + encodeURIComponent(gAuthnMethods2) + String.fromCharCode(0x26)
		+ 'authnIPs=' + gAuthnIPs + String.fromCharCode(0x26)
		+ 'authnInstitutions=' + authnEntity;

		
		
		
		

	    var gPageId = "pageid-content";
	    var gVariant = "full-text";

	    
		// Not completely done
		var eventType = "full-text";
		var accessType;
		if (siqIsOpenAccess == 'true') {
		    accessType = 'SOA';
		} else {
		    accessType = 'subscription';
		}
		    
		var NTPT_PGEXTRA =
		    commonString + String.fromCharCode(0x26)
		    + 'event_type=' + eventType + String.fromCharCode(0x26)
		    + 'publication_date=' + siqPubDate + String.fromCharCode(0x26)
		    + 'access_type=' + accessType + String.fromCharCode(0x26)
		    + 'doi=' + siqDOI ;
		    
		

	    // alert("NTPT_PGEXTRA is " + NTPT_PGEXTRA);
	</script><link rel="stylesheet" type="text/css" media="all" href="/resource/css/hw20.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/resource/css/h20-oup-header.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/resource/css/h20-oup-footer.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/resource/css/h20-oup-sidebars.css" />
      <link type="text/css" media="all" rel="stylesheet" href="/site/resource/jnci_h20.css" />
      <link rel="stylesheet" type="text/css" href="/resource/css/print.css" media="print" /><script type="text/javascript" src="/resource/js/main.js"></script><link rel="stylesheet" type="text/css" media="all"
            href="http://oi-underbar.ifactory.com/underbar/css/pf_oiunderbar.css" />
      <link rel="stylesheet" type="text/css" media="screen"
            href="http://gab.cookie.oup.com/aws-cookie/jquery.fancybox-1.3.4_1.css" /><script type="text/javascript" src="/resource/js/oup_ad_size.js"></script></head>
   <body class="general_page journal jnci">
      <div class="hw-gen-page pagetype-content hw-pub-id-article" id="pageid-content"
           itemscope="itemscope"
           itemtype="http://schema.org/ScholarlyArticle">
         <noscript>
            <p>We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of
               cookies. You can change your cookie settings at any time. <a href="http://global.oup.com/cookiepolicy/">Find out more</a></p>
         </noscript>
         
         
         <p class="hide">
            <a href="#content">Skip Navigation</a>
            
         </p>
         
         
         <div id="secondary_nav">
            <strong id="page_logo" title="Oxford Journals"><a href="http://www.oxfordjournals.org/"><span>Oxford Journals</span></a></strong>
            
            <ul>
               <li id="nav_contact_us" title="Contact Us"><a href="http://www.oxfordjournals.org/contact_us.html"><span>Contact Us</span></a></li>
               <li id="nav_my_basket" title="My Basket"><a href="https://secure.oxfordjournals.org/basket.html"><span>My Basket</span></a></li>
               <li id="nav_my_account" title="My Account"><a href="http://services.oxfordjournals.org/cgi/tslogin?url=http://www.oxfordjournals.org/service/Register"><span>My 
                        
                        Account</span></a></li>
            </ul>
            
         </div>
         
         
         <div id="header">
            
            <h1 id="page_title" title="JNCI J Natl Cancer Inst"><a href="/"><span>
                     JNCI J Natl Cancer Inst
                     </span></a></h1>
            
         </div>
         
         
         <div id="primary_nav">
            
            <ul>
               <li id="nav_about_this_journal" title="About This Journal">
                  <a href="http://www.oxfordjournals.org/jnci/about.html">
                     
                     <span>About This Journal</span>
                     </a>
                  
               </li>
               <li id="nav_contact_this_journal" title="Contact This Journal"><a href="/cgi/feedback/"><span>Contact This Journal</span></a></li>
               <li id="nav_subscriptions" title="Subscriptions">
                  <a href="http://www.oxfordjournals.org/jnci/access_purchase/buy_online.html">
                     
                     <span>Subscriptions</span>
                     </a>
                  
               </li>
               <li id="nav_current_issue" title="Current"><a href="/content/current"><span>View Current Issue (Volume 107 Issue 10 October 2015)</span></a></li>
               <li id="nav_archive" title="Archive"><a href="/content/by/year"><span>Archive</span></a></li>
               <li id="nav_search" title="Search"><a href="/search"><span>Search</span></a></li>
            </ul>
            
         </div>
         
         
         <div id="user_nav">
            
            <div class="header-ac-elements">
               
               <div id="authstring">
                  
                  <ul>
                     <li class="subscr-ref">Institution:  MIT Libraries</li>
                     <li class="no-left-border">
                        <a href="/login?uri=http%3A%2F%2Fjnci.oxfordjournals.org%2Fcontent%2F89%2F11%2F790.full">
                           Sign In as Personal Subscriber
                           </a>
                        
                     </li>
                  </ul>           
                  
               </div>   
               
            </div>
            
         </div>
         
         
         <ul id="site-breadcrumbs">
            <li class="first"><a href="http://services.oxfordjournals.org/cgi/tslogin?url=http%3A%2F%2Fwww.oxfordjournals.org">Oxford Journals</a></li>
            <li><span class="breadcrumb_subjects"><a href="http://www.oxfordjournals.org/subject/medicine/"
                     class="breadcrumb_subject">Medicine &amp; Health</a></span></li>
            <li><a href="/">JNCI J Natl Cancer Inst</a></li>
            <li><a href="/content/89/11.toc">
                  <span xmlns="" class="volume-value">Volume 89</span>
                  <span xmlns="" class="issue-value"> Issue 11</span></a></li>
            <li>Pp. <span class="slug-pages">
                  790-795.
                  </span></li>
         </ul>
         
         
         
         
         <div id="oas_top" class="ad_hidden">
            <iframe id="id_advertframe_top"
                    src="/resource/htmlfiles/advert.html?p=Top&amp;u=jnci.oxfordjournals.org/content/89/11/790.full"
                    width="0"
                    height="0"
                    frameborder="0"
                    scrolling="no"
                    class="resize_ad"></iframe>
            
         </div>
         
         
         <a name="content"></a>
         
         
         <div id="h20_page"></div>
         
         <div id="content-block">
            <div class="article fulltext-view" itemprop="articleBody"><span class="highwire-journal-article-marker-start"></span><h1 id="article-title-1" itemprop="headline">Economic Implications of Hepatic Arterial Infusion Chemotherapy in Treatment of Nonresectable Colorectal Liver Metastases</h1>
               <div class="contributors">
                  <ol class="contributor-list" id="contrib-group-1">
                     <li class="contributor" id="contrib-1" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Isabelle+Durand-Zaleski&amp;sortspec=date&amp;submit=Submit">Isabelle Durand-Zaleski</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-2" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=B%C3%A9atrice+Roche&amp;sortspec=date&amp;submit=Submit">Béatrice Roche</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-3" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Pierre-Louis+Fagniez&amp;sortspec=date&amp;submit=Submit">Pierre-Louis Fagniez</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-4" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Jean-Paul+Le+Bourgeois&amp;sortspec=date&amp;submit=Submit">Jean-Paul Le Bourgeois</a></span> and 
                     </li>
                     <li class="last" id="contrib-5"><span class="name"><a class="name-search"
                              href="/search?author1=Pascal+Piedbois&amp;sortspec=date&amp;submit=Submit">Pascal Piedbois</a></span></li>
                  </ol>
                  <ol class="affiliation-list">
                     <li class="aff"><a id="aff-1" name="aff-1"></a><address>Henri Mondor Hospital, <span class="addr-line">Paris, France</span></address>
                     </li>
                  </ol>
                  <ol class="corresp-list">
                     <li class="corresp" id="corresp-1"><em>Correspondence to:</em> Isabelle Durand-Zaleski, M.D., Ph.D., Santé Publique, Hôpital Henri Mondor, 51 avenue du Maréchal de Lattre de Tassigny,
                        94010 Créteil, France.
                     </li>
                  </ol>
               </div>
               <div class="contributors">
                  <ol class="contributor-list" id="contrib-group-2">
                     <li class="contributor" id="contrib-6" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Marc+Buyse&amp;sortspec=date&amp;submit=Submit">Marc Buyse</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-7" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Robert+Carlson&amp;sortspec=date&amp;submit=Submit">Robert Carlson</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-8" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Michael+J.+O'Conell&amp;sortspec=date&amp;submit=Submit">Michael J. O'Conell</a></span> and 
                     </li>
                     <li class="last" id="contrib-9"><span class="name"><a class="name-search"
                              href="/search?author1=Philippe+Rougier&amp;sortspec=date&amp;submit=Submit">Philippe Rougier</a></span></li>
                  </ol>
                  <ol class="affiliation-list">
                     <li class="aff"><a id="aff-2" name="aff-2"></a><address>International Institute for Drug Development, <span class="addr-line">Brussels, Belgium</span></address>
                     </li>
                     <li class="aff"><a id="aff-3" name="aff-3"></a><address>Stanford University, <span class="addr-line">Palo Alto, CA</span></address>
                     </li>
                     <li class="aff"><a id="aff-4" name="aff-4"></a><address>Mayo Clinic, <span class="addr-line">Rochester, MN</span></address>
                     </li>
                     <li class="aff"><a id="aff-5" name="aff-5"></a><address>Groupe d'Etudes et de Recherches des Tumeurs Hépatiques and Association Universitaire de Recherche en Chirurgie, <span class="addr-line">Paris</span></address>
                     </li>
                  </ol>
               </div>
               <div class="contributors">
                  <ol class="contributor-list" id="contrib-group-3">
                     <li class="contributor" id="contrib-10" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Alfred+E.+Chang&amp;sortspec=date&amp;submit=Submit">Alfred E. Chang</a></span> and 
                     </li>
                     <li class="last" id="contrib-11"><span class="name"><a class="name-search"
                              href="/search?author1=Vernon+K.+Sondak&amp;sortspec=date&amp;submit=Submit">Vernon K. Sondak</a></span></li>
                  </ol>
                  <ol class="affiliation-list">
                     <li class="aff"><a id="aff-6" name="aff-6"></a><address>University of Michigan Medical Center, <span class="addr-line">Ann Arbor</span></address>
                     </li>
                  </ol>
               </div>
               <div class="contributors">
                  <ol class="contributor-list" id="contrib-group-4">
                     <li class="contributor" id="contrib-12" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Margaret+M.+Kemeny&amp;sortspec=date&amp;submit=Submit">Margaret M. Kemeny</a></span> and 
                     </li>
                     <li class="last" id="contrib-13"><span class="name"><a class="name-search"
                              href="/search?author1=Tim+G.+Allen-Mersh&amp;sortspec=date&amp;submit=Submit">Tim G. Allen-Mersh</a></span></li>
                  </ol>
                  <ol class="affiliation-list">
                     <li class="aff"><a id="aff-7" name="aff-7"></a><address>North Shore University Hospital, <span class="addr-line">Manhasset, NY</span></address>
                     </li>
                     <li class="aff"><a id="aff-8" name="aff-8"></a><address>Chelsea and Westminster Hospital, <span class="addr-line">London, U.K</span></address>
                     </li>
                  </ol>
                  <ul class="history-list">
                     <li xmlns:hwp="http://schema.highwire.org/Journal" class="received"
                         hwp:start="1997-01-28"><span class="received-label">Received </span>January 28, 1997.
                     </li>
                     <li xmlns:hwp="http://schema.highwire.org/Journal" class="rev-recd"
                         hwp:start="1997-03-18"><span class="rev-recd-label">Revision received </span>March 18, 1997.
                     </li>
                     <li xmlns:hwp="http://schema.highwire.org/Journal" class="accepted"
                         hwp:start="1997-03-28"><span class="accepted-label">Accepted </span>March 28, 1997.
                     </li>
                  </ul>
               </div>
               <div class="section abstract" id="abstract-1" itemprop="description">
                  <div class="section-nav">
                     <div class="nav-placeholder"> </div><a href="#sec-1" title="Subjects and Methods" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>Abstract</h2>
                  
                  <p id="p-5"><em>Background:</em> Approximately 20% of patients with colorectal cancer die of metastases confined to the liver. A metaanalysis recently performed
                     by our group confirmed that in these patients hepatic arterial infusion of 5-fluoro-2′- deoxyuridine, compared with intravenous
                     chemotherapy with fluoropyrimidines or supportive care (including symptom palliation when necessary), improved tumor response.
                     <em>Purpose:</em> Because of the high cost of hepatic arterial infusion, we undertook a cost-effectiveness analysis that related the cost of
                     such therapy to its medical efficacy. <em>Methods:</em> The patient population was drawn from the seven randomized clinical trials included in the meta-analysis and included individual
                     data on 654 patients. Of these seven trials, five compared hepatic arterial infusion and intravenous chemotherapy and two
                     compared hepatic arterial infusion and a control group in which some patients could be left untreated. Patients assigned to
                     receive hepatic arterial infusion made up the hepatic arterial infusion group; the other patients constituted the control
                     group. The measures of efficacy were survival and tumor response. Health-care costs (in 1995 U.S. dollars) were computed over
                     the duration of patient followup and were derived from actual costs in two centers, one at Henri Mondor Hospital (Paris, France)
                     and the other at Stanford University Medical Center (Palo Alto, CA). The total cost of treatment included the initial procedure,
                     chemotherapy cycles, and main complications. <em>Results:</em> The mean gain in life expectancy in the hepatic arterial infusion group compared with the control group was 3.2 months (standard
                     error = 1.0 month). For patients treated by hepatic arterial infusion in Paris, the hepatic arterial infusion pump, initial
                     hospitalization, and the entire process (including follow- up and complications) cost, on average, $8400, $15 172, and $29
                     562, respectively; in Palo Alto, these costs were $4700, $13 784, and $25 208, respectively. For patients in the control groups
                     in Paris and Palo Alto, the total treatment costs were, on average, $9926 and $5928. The additional costs of hepatic arterial
                     infusion over control treatment were $19 636 in Paris and $19 280 in Palo Alto. The costeffectiveness (i.e., the additional
                     cost divided by the additional benefit) with respect to survival of the patients in the hepatic arterial infusion group compared
                     with the patients in the control group was $73 635 per life-year in Paris and $72 300 per life-year in Palo Alto. <em>Conclusions and Implications:</em> The cost-effectiveness of localized chemotherapy for colorectal liver metastases is within the range of accepted treatments
                     for serious medical conditions, although it might be considered borderline by policy-makers in some countries. Prospective
                     clinical trials should be conducted to more definitively answer this question.
                  </p>
                  
               </div>
               <p id="p-6">Economic analysis is an increasingly important component in the evaluation of new procedures for their ability to improve
                  medical outcomes for patients with diseases. The objective of economic analysis applied to innovative therapeutic procedures
                  is to relate their costs to the improvement produced in medical outcome. In a recently published meta-analysis (<a id="xref-ref-1-1" class="xref-bibr" href="#ref-1"><em>1</em></a>), our group confirmed that, among patients with nonresectable liver metastases from colorectal cancer, hepatic arterial infusion
                  of 5-fluoro-2′-deoxyuridine, compared with intravenous chemotherapy with fluoropyrimidines, tripled the likelihood of tumor
                  response. The meta-analysis also showed a statistically significant advantage for hepatic arterial infusion over intravenous
                  chemotherapy in terms of survival when all trials were taken into account (<a id="xref-ref-2-1" class="xref-bibr" href="#ref-2"><em>2</em></a>–<a id="xref-ref-8-1" class="xref-bibr" href="#ref-8"><em>8</em></a>) and a trend in favor of hepatic arterial infusion when survival analyses were restricted to trials comparing hepatic arterial
                  infusion with intravenous chemotherapy (<a id="xref-ref-2-2" class="xref-bibr" href="#ref-2"><em>2</em></a>–<a id="xref-ref-6-1" class="xref-bibr" href="#ref-6"><em>6</em></a>).
               </p>
               <p id="p-7">Colorectal cancer is one of the most common cancers in developed countries and results in liver metastases in 30%-40% of affected
                  individuals (<a id="xref-ref-9-1" class="xref-bibr" href="#ref-9"><em>9</em></a>). Approximately 20% of patients die of metastases confined to the liver. The medical effectiveness and the cost of chemotherapy
                  for patients with incurable liver metastases are important public health issues, but the high cost of hepatic arterial infusion
                  could become a disincentive to hospital administrators and third-party payors (<a id="xref-ref-10-1" class="xref-bibr" href="#ref-10"><em>10</em></a>). At a time when most developed countries face increasing constraints from their health-care budgets, high-cost procedures
                  affecting a large number of individuals are a primary concern to decision-makers.
               </p>
               <p id="p-8">As suggested by the editorial accompanying the publication of the meta-analysis on hepatic arterial infusion (<a id="xref-ref-10-2" class="xref-bibr" href="#ref-10"><em>10</em></a>), we undertook an economic analysis that relates the additional cost of hepatic arterial infusion over conventional treatments
                  to its additional medical benefits. Our objective was to determine the cost-effectiveness of treatments from the perspective
                  of a decision- maker involved in prospective health-care choices.
               </p>
               <div class="section" id="sec-1">
                  <div class="section-nav"><a href="#abstract-1" title="Abstract" class="prev-section-link"><span>Previous Section</span></a><a href="#sec-7" title="Results" class="next-section-link"><span>Next Section</span></a></div>
                  
                  <h2>Subjects and Methods</h2>
                  
                  <div id="sec-2" class="subsection">
                     
                     <h3>Patient Population and Clinical End Points</h3>
                     
                     <p id="p-9">Individual patient data were retrieved for the meta-analysis by the Meta-Analysis Group In Cancer in 1996. All seven clinical
                        trials were included in the economic analysis. Five of these trials directly compared hepatic arterial infusion with intravenous
                        chemotherapy (<a id="xref-ref-2-3" class="xref-bibr" href="#ref-2"><em>2</em></a>–<a id="xref-ref-6-2" class="xref-bibr" href="#ref-6"><em>6</em></a>), and two compared hepatic arterial infusion with symptom palliation or ad libitum intravenous chemotherapy (in most cases,
                        with fluorouracil alone) (<a id="xref-ref-7-1" class="xref-bibr" href="#ref-7"><em>7</em></a>,<a id="xref-ref-8-2" class="xref-bibr" href="#ref-8"><em>8</em></a>). The total number of patients included in these trials was 654. We will hereafter refer to the group of patients assigned
                        to receive hepatic arterial infusion as the HAI group and to the group of patients who received either symptom palliation
                        or intravenous chemotherapy as the control group.
                     </p>
                     
                     <p id="p-10">The clinical end points were survival and tumor response, both of which provided estimates of effectiveness in the cost-effectiveness
                        analysis. All analyses of the end points were made following the intention-to-treat principle. The cost-effectiveness analysis
                        considered the additional costs of obtaining a longer survival or a higher tumor response rate through the use of hepatic
                        arterial infusion. One trial (<a id="xref-ref-2-4" class="xref-bibr" href="#ref-2"><em>2</em></a>) was included in the tumor response analysis but not in the survival analysis, since individual patient data were not available
                        in this trial. The life expectancy was estimated by the mean survival obtained from the Kaplan-Meier curve, which is equal
                        to the area under the survival curves (<a id="xref-fig-1-1" class="xref-fig" href="#F1">Fig. 1</a>). Gains in life expectancy were discounted at a 5% yearly rate. The gain in life expectancy in the HAI group compared with
                        the control group was estimated by the difference in mean survival (<a id="xref-ref-11-1" class="xref-bibr" href="#ref-11"><em>11</em></a>). Computations were made by use of the SAS statistical software package (SAS Institute, Inc., Cary, NC).
                     </p>
                     
                     <div id="F1" class="fig pos-anchor odd">
                        <div class="fig-inline"><img alt="Fig. 1." src="790/F1.medium.gif" /></div>
                        <div class="fig-caption"><span class="fig-label"><strong>Fig. 1.</strong></span> 
                           
                           <p id="p-11" class="first-child">Overall survival curves among patients treated with hepatic arterial infusion (HAI) compared with control patients. Survival
                              time was discounted at a 5% yearly rate. <em>P</em> value is two-sided.
                           </p>
                           
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                     
                  </div>
                  
                  <div id="sec-3" class="subsection">
                     
                     <h3>Economic Analysis</h3>
                     
                     <p id="p-12">We computed costs on an intention-to-treat basis rather than on the basis of actual treatment for the following reasons: 1)
                        to ensure consistency between computations of costs and outcome and 2) to provide decision-makers with planning and budgetary
                        tools that would allow prospective estimations of the cost of alternative therapeutic strategies (<a id="xref-ref-11-2" class="xref-bibr" href="#ref-11"><em>11</em></a>–<a id="xref-ref-13-1" class="xref-bibr" href="#ref-13"><em>13</em></a>). The valuation method used health-care (hospital and ambulatory) costs standardized in one European center (Henri Mondor
                        Hospital, Paris, France) and one U.S. center (Stanford University Medical Center, Palo Alto, CA). Thus, health-care costs
                        were obtained from the accounting records of patients recently or currently treated at one of the two sites and are not based
                        on the actual costs of treating the patients in the trials. This method of indirect standardization allowed us to compute
                        the costs of a therapeutic strategy undertaken in different medical centers and has been applied to multicenter trials as
                        well as to meta-analyses (<a id="xref-ref-14-1" class="xref-bibr" href="#ref-14"><em>14</em></a>–<a id="xref-ref-16-1" class="xref-bibr" href="#ref-16"><em>16</em></a>).
                     </p>
                     
                  </div>
                  
                  <div id="sec-4" class="subsection">
                     
                     <h3>Type of Analysis</h3>
                     
                     <p id="p-13">We computed a cost per year of added survival. The additional cost of hepatic arterial infusion over control treatment was
                        divided by the additional medical benefit. Let <em>C1</em> and <em>C2</em> be the respective costs of control treatment and hepatic arterial infusion treatment, whose medical outcomes are <em>R1</em> and <em>R2</em>, respectively; the cost-effectiveness ratio of hepatic arterial infusion was defined as (C2 − C1)/(R2 − R1), where <em>C1</em> and <em>C2</em> are expressed in monetary terms and <em>R1</em> and <em>R2</em> in unidimensional medical units. The issue of quality of life was not addressed, since no data were available on this end
                        point (<a id="xref-ref-11-3" class="xref-bibr" href="#ref-11"><em>11</em></a>,<a id="xref-ref-17-1" class="xref-bibr" href="#ref-17"><em>17</em></a>).
                     </p>
                     
                  </div>
                  
                  <div id="sec-5" class="subsection">
                     
                     <h3>Cost Computations</h3>
                     
                     <p id="p-14">Costs were computed over the duration of patient follow-up. The perspective of the health-care system was used in all cost
                        estimates. Costs to society were not included because individual data on work status were not available (<a id="xref-ref-11-4" class="xref-bibr" href="#ref-11"><em>11</em></a>–<a id="xref-ref-13-2" class="xref-bibr" href="#ref-13"><em>13</em></a>).
                     </p>
                     
                     <p id="p-15">Direct medical costs included the following: 1) cost of purchasing the devices (nonreusable implanted arterial pump and systemic
                        port) and cost of the procedures and of hospitalizations; 2) cost of ambulatory treatment facilities (Paris) or outpatient
                        clinic without hospitalization (Palo Alto) for administering chemotherapy; 3) cost of chemotherapy drugs, computed from data
                        on the number of chemotherapy cycles per patient in the trials; 4) costs of follow-up tests— angioscintigraphy in the HAI
                        group (three in Paris and one in Palo Alto), an abdominal computed tomography scan every 3rd month, chest x ray, liver function
                        tests, and blood cell counts every month; and 5) cost of treatment for therapy-related severe toxic effects (i.e., complications).
                        Overhead costs included administrative and support services and capital costs. Protocol-driven costs were excluded. No costs
                        were attached to patients assigned to the symptom palliation groups (<a id="xref-ref-7-2" class="xref-bibr" href="#ref-7"><em>7</em></a>,<a id="xref-ref-8-3" class="xref-bibr" href="#ref-8"><em>8</em></a>), assuming that the costs of symptom palliation were the same for all patients in the trials, regardless of their randomized
                        treatment group.
                     </p>
                     
                     <p id="p-16">Values of hospital resources were drawn from two cost-accounting systems, one in Palo Alto by use of a computer software package
                        from TSI 2-Transition Systems Inc. (Boston, MA) and the other in Paris by use of the hospitalaccounting charts. These costs
                        were retrieved by one of us (I. Durand-Zaleski), who visited both sites. They were actual costs (not charges) in the oncology,
                        surgery, and outpatient clinic departments.
                     </p>
                     
                     <p id="p-17">Hospital costs of treatments included medical and nonmedical salaries, secretarial and housekeeping expenses, office supplies,
                        medical tests, drugs, blood products, and medical supplies. Drug costs were taken from the pharmacy formulary; delivery costs
                        were included either in the drug costs (Palo Alto) or in the overhead costs (Paris). The costs of supplies were the purchase
                        prices from the manufacturer. Overhead costs represented 25% of total costs in Paris and were computed as a separate line
                        item, whereas they were included in the cost of each item in Palo Alto.
                     </p>
                     
                     <p id="p-18">The toxic effects of treatment were considered for the purpose of this study, insofar as they generated costs for the health-care
                        system. The frequency of these toxic effects was estimated from the published trials included in the metaanalysis (2-8). The
                        cost of treatment for toxic effects was estimated by multiplying the unit cost for treatment of each toxic effect by the frequency
                        of its occurrence (<a id="xref-fig-2-1" class="xref-fig" href="#F2">Table 1</a>). Data on practice patterns for the management of toxic effects related to treatment and hospital costs were derived from
                        the hospitalaccounting systems.
                     </p>
                     
                     <div id="F2" class="fig pos-anchor even">
                        <div class="fig-inline"><img alt="Figure" src="790/F2.medium.gif" /></div>
                     </div>
                     
                     <p id="p-19">The reference year for cost computations was 1995. All costs were converted to 1995 U.S. dollars. Costs were discounted at
                        a 5% yearly rate.
                     </p>
                     
                  </div>
                  
                  <div id="sec-6" class="subsection">
                     
                     <h3>Sensitivity Analysis</h3>
                     
                     <p id="p-20"><strong>Alternative comparator.</strong> The reference strategy used to compute the additional cost of hepatic arterial infusion in the baseline analysis was a combination
                        of intravenous chemotherapy and ad libitum symptom palliation, as was found in the control groups considered in the meta-analysis.
                        A relevant therapeutic option is intravenous chemotherapy, which is preferred to symptom palliation in some countries. We
                        performed a sensitivity analysis of the cost-effectiveness ratios, assuming that the only comparator for hepatic arterial
                        infusion was intravenous chemotherapy and excluding from the analysis patients who received only symptom palliation. The trials
                        kept for this analysis were the five trials that directly compared hepatic arterial infusion with intravenous chemotherapy
                        (<a id="xref-ref-2-5" class="xref-bibr" href="#ref-2"><em>2</em></a>–<a id="xref-ref-6-3" class="xref-bibr" href="#ref-6"><em>6</em></a>) and included 391 patients. The medical outcomes were survival and tumor response, as evaluated in the meta-analysis for
                        the five trials considered (<a id="xref-ref-1-2" class="xref-bibr" href="#ref-1"><em>1</em></a>).
                     </p>
                     
                  </div>
                  
               </div>
               <div class="section" id="sec-7">
                  <div class="section-nav"><a href="#sec-1" title="Subjects and Methods" class="prev-section-link"><span>Previous Section</span></a><a href="#sec-12" title="Discussion" class="next-section-link"><span>Next Section</span></a></div>
                  
                  <h2>Results</h2>
                  
                  <div id="sec-8" class="subsection">
                     
                     <h3>Medical Outcomes</h3>
                     
                     <p id="p-21">The results of the meta-analysis were published previously (<a id="xref-ref-1-3" class="xref-bibr" href="#ref-1"><em>1</em></a>). Mean survival time (discounted) was 16.3 months (standard error = 0.7 month) for patients assigned to receive hepatic arterial
                        infusion compared with 13.1 months (standard error = 0.7 month) for control patients. The mean gain in life expectancy in
                        the HAI group was 3.2 months (standard error = 1.0 month).
                     </p>
                     
                  </div>
                  
                  <div id="sec-9" class="subsection">
                     
                     <h3>Medical Costs</h3>
                     
                     <p id="p-22">Costs for the hepatic arterial infusion strategy were as follows: In France, the purchase price and cost of insertion of an
                        arterial pump and the cost of an 11-day hospital stay were $23 572, and the total cost of the hepatic arterial infusion treatment
                        was $29 562 (which included the costs of chemotherapy as well as follow-up and treatment for toxic effects related to therapy).
                        In Palo Alto, the pump was inserted in the course of a 7-day hospitalization, the total cost of the pump and the procedure
                        was $18 484, and the total cost of hepatic arterial infusion was $25 208.
                     </p>
                     
                     <p id="p-23">In Paris, costs for control patients (intravenous chemotherapy or symptom palliation) were $629 for the initial procedure
                        (insertion of a systemic port or simple intravenous chemotherapy), and the total cost was $9926 (including the cost of chemotherapy
                        with hospitalization and tests). In Palo Alto, initial procedure costs for the control group were $512, and the total cost
                        was $5928. Patients did not require hospitalization for administering chemotherapy.
                     </p>
                     
                     <p id="p-24">Costs of treatment of toxic effects per episode are presented in <a id="xref-fig-3-1" class="xref-fig" href="#F3">Table 2</a>. The cost of toxicity multiplied by the probability of its occurrence (<a id="xref-fig-2-2" class="xref-fig" href="#F2">Table 1</a>) was added to the cost of the corresponding strategy.
                     </p>
                     
                     <p id="p-25">Detailed computations of the above costs are presented in <a id="xref-fig-4-1" class="xref-fig" href="#F4">Table 3</a>.
                     </p>
                     
                  </div>
                  
                  <div id="sec-10" class="subsection">
                     
                     <h3>Cost-effectiveness</h3>
                     
                     <p id="p-26">The cost-effectiveness of hepatic arterial infusion compared with control treatment is the additional cost divided by the
                        additional medical benefit. The cost-effectiveness ratios in Paris and in Palo Alto were, respectively, $73 635 and $72 300
                        per year of added survival. Cost-effectiveness ratios within the 95% confidence interval for survival are presented in <a id="xref-fig-5-1" class="xref-fig" href="#F5">Fig. 2</a>. The length of the <em>x</em> axis on <a id="xref-fig-5-2" class="xref-fig" href="#F5">Fig. 2</a> represents the full range of the 95% confidence interval for the survival advantage of hepatic arterial infusion over intravenous
                        chemotherapy or symptom palliation.
                     </p>
                     
                  </div>
                  
                  <div id="sec-11" class="subsection">
                     
                     <h3>Sensitivity Analysis</h3>
                     
                     <p id="p-27"><strong>Alternative comparator</strong>. We computed tumor response and survival in a subset of 391 patients included in the five trials comparing hepatic arterial
                        infusion with intravenous chemotherapy; we assumed that the reference strategy for hepatic arterial infusion chemotherapy
                        was intravenous chemotherapy, and we excluded from the comparison patients who were treated for symptom palliation only. The
                        gain in tumor response rate for the HAI group was 27% (standard error = 4%). The average gain in life expectancy for the HAI
                        group was 2.1 months (standard error = 1.8 months). Because these results were computed on the basis of intention to treat,
                        they did not take into account the fact that about 20% of the patients crossed over from intravenous chemotherapy to hepatic
                        arterial infusion.
                     </p>
                     
                     <p id="p-28">The costs of the hepatic arterial infusion strategy were the same as above. In France, the costs of the intravenous chemotherapy
                        strategy were $1047 for the insertion of a systemic port and $16 722 in total; in the United States, these costs were $854
                        and $10 031, respectively.
                     </p>
                     
                     <p id="p-29">Detailed computations of the costs used in the sensitivity analysis are presented in <a id="xref-fig-6-1" class="xref-fig" href="#F6">Table 4</a>.
                     </p>
                     
                     <p id="p-30">When total cumulated survival was the outcome considered, the denominator of the cost-effectiveness ratio was 2.1 months,
                        and the cost-effectiveness ratios were $73 680 and $87 012 per year of added survival in Paris and Palo Alto, respectively.
                        When tumor response was the intermediate outcome considered, the denominator of the cost-effectiveness ratio was the difference
                        in response rate (27%), and the cost-effectiveness ratios were $47 231 and $55 776 per tumor response achieved in Paris and
                        in Palo Alto, respectively.
                     </p>
                     
                     <div id="F3" class="fig pos-anchor odd">
                        <div class="fig-inline"><img alt="Figure" src="790/F3.medium.gif" /></div>
                     </div>
                     
                     <div id="F4" class="fig pos-anchor even">
                        <div class="fig-inline"><img alt="Figure" src="790/F4.medium.gif" /></div>
                     </div>
                     
                     <p id="p-31"><strong>Discount rate</strong>. When costs and survival were not discounted, the total costs for hepatic arterial infusion and for control treatment (symptom
                        palliation or intravenous chemotherapy) were, respectively, $29 582 and $9936 in Paris and $25 229 and $4920 in Palo Alto.
                        The undiscounted mean survivals for patients in the HAI group and for patients in the control group were 18.4 months (standard
                        error = 0.9 month) and 14.7 months (standard error = 0.9 month), respectively, and the mean gain in life expectancy was 3.7
                        months (standard error = 1.3 months) for patients in the HAI group compared with patients in the control group. The cost-effectiveness
                        ratios of hepatic arterial infusion compared with control treatment were $63 717 in Paris and $65 867 in Palo Alto per year
                        of added survival.
                     </p>
                     
                     <div id="F5" class="fig pos-anchor odd">
                        <div class="fig-inline"><img alt="Fig. 2." src="790/F5.medium.gif" /></div>
                        <div class="fig-caption"><span class="fig-label"><strong>Fig. 2.</strong></span> 
                           
                           <p id="p-32" class="first-child">Cost-effectiveness ratios for hepatic arterial infusion (HAI) versus control treatment (intravenous chemotherapy or symptom
                              palliation). The horizontal axis represents the expected gain in life expectancy obtained by HAI treatment versus control
                              treatment. The vertical axis is the cost-effectiveness ratio in 1995 U.S. dollars per life-year.
                           </p>
                           
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                     
                  </div>
                  
               </div>
               <div class="section" id="sec-12">
                  <div class="section-nav"><a href="#sec-7" title="Results" class="prev-section-link"><span>Previous Section</span></a><a href="#fn-group-1" title="Footnotes" class="next-section-link"><span>Next Section</span></a></div>
                  
                  <h2>Discussion</h2>
                  
                  <p id="p-33">Colon cancer with unresectable liver metastases represents a major public health problem because of its frequency and the
                     cost of its treatment. The objective of economic analysis is to provide relevant information for health-care decision-makers
                     in charge of allocating resources (<a id="xref-ref-17-2" class="xref-bibr" href="#ref-17"><em>17</em></a>,<a id="xref-ref-18-1" class="xref-bibr" href="#ref-18"><em>18</em></a>). In the present costeffectiveness analysis applied to the results of a meta-analysis of cancer liver metastasis treatments,
                     the outcomes and the costs of hepatic arterial infusion versus intravenous chemotherapy or supportive care were compared.
                     The additional medical cost of hepatic arterial infusion over systemic intravenous chemotherapy or symptom palliation was
                     approximately $70 000 per year of added survival.
                  </p>
                  
                  <p id="p-34">This meta-analysis and economic evaluation suggest that the cost-effectiveness of hepatic arterial infusion for treatment
                     of colorectal liver metastases is within the range of accepted treatments for other severe medical conditions. In a 1993 survey
                     by the French Ministry of Health, the costs of hemodialysis were estimated to be $70 000-$90 000 per year. The costs found
                     for hepatic arterial infusion were higher than the costs of the treatment of advanced colon cancer found between 1990 and
                     1991 (<a id="xref-ref-19-1" class="xref-bibr" href="#ref-19"><em>19</em></a>) for patients enrolled in a staff-model Health Maintenance Organization, but they were comparable for intravenous chemotherapy.
                     The cost per life-year of detecting and treating cancers has been estimated to vary between $20 000 and $120 000 (<a id="xref-ref-20-1" class="xref-bibr" href="#ref-20"><em>20</em></a>–<a id="xref-ref-24-1" class="xref-bibr" href="#ref-24"><em>24</em></a>).
                  </p>
                  
                  <div id="F6" class="fig pos-anchor even">
                     <div class="fig-inline"><img alt="Figure" src="790/F6.medium.gif" /></div>
                  </div>
                  
                  <p id="p-35">Laupacis et al. (<a id="xref-ref-25-1" class="xref-bibr" href="#ref-25"><em>25</em></a>) proposed a classification of technologies according to their cost-utility ratios. The cost-effectiveness ratio of hepatic
                     arterial infusion versus intravenous chemotherapy or symptom palliation falls within the group of strategies for which society
                     has to spend more than $100 000 per quality-adjusted life-year, which represented the least cost-effective category in their
                     classification.
                  </p>
                  
                  <p id="p-36">The costs of infusing chemotherapy in the hepatic artery could possibly be reduced by use of a port-a-cath (a permanent catheter
                     that can be connected to an external pump as necessary for delivery of chemotherapeutic agents) implanted in the artery by
                     a procedure involving radiologic monitoring and no surgery. This approach, currently under trial in Japan and Italy, could
                     reduce the costs by suppressing the need for surgery as well as the need for the purchase of an expensive piece of equipment
                     (<a id="xref-ref-26-1" class="xref-bibr" href="#ref-26"><em>26</em></a>).
                  </p>
                  
                  <p id="p-37">We did not consider the overall burden of the disease to society. Costs to society would include lost labor, compensations,
                     and other expenditures incurred by the patient or the family in the course of the disease. Data from other trials (<a id="xref-ref-8-4" class="xref-bibr" href="#ref-8"><em>8</em></a>) indicate that lost labor is higher for patients who received hepatic arterial infusion than for patients who received intravenous
                     chemotherapy or symptom palliation, in part because the former patients live longer without resuming work. We did not include
                     data on reimbursement and financial incentives; information on patient health-care insurance is relevant to the flow of money
                     into the medical centers, but not to the outflow (costs). Data on quality of life were not available from the trials. However,
                     if tumor response could be considered as a surrogate marker for quality of life in symptomatic patients, the hepatic arterial
                     infusion strategy would appear to be more attractive.
                  </p>
                  
                  <p id="p-38">Costs were computed from the perspective of the health-care systems in France and in the United States, meaning that only
                     costs to the health-care system were included and other costs, such as societal costs, were excluded. Health-care spending
                     in France is comparable to that in most industrialized countries, except the United States, where spending on hospital care
                     is, in real terms, about two times higher (<a id="xref-ref-27-1" class="xref-bibr" href="#ref-27"><em>27</em></a>). The relatively low costs of hepatic arterial infusion found in Palo Alto compared with the costs in Paris result from a
                     lower price paid in the United States for the infusion device and from an efficient U.S. policy of reducing the length of
                     hospital stay for these patients and delivering chemotherapy in outpatient clinics.
                  </p>
                  
                  <p id="p-39">Applying economic evaluation to the results of a metaanalysis involves some degree of modeling—first because few trials have
                     collected data on resource use and second because unit values of resources used have to be standardized. Using medical records
                     from the Henri Mondor Hospital (Paris) and from Stanford University Medical Center (Palo Alto), we modeled the medical management
                     of patients with complications. While practice patterns may differ from one institution to another, the overall burden of
                     complications represented a small percentage of the total cost and, therefore, may not have affected the results much. For
                     a similar reason, the uncertainty about the exact prevalence of complications in the two treatment groups cannot alter our
                     general conclusions.
                  </p>
                  
                  <p id="p-40">Sensitivity analysis provides a range of possible costeffectiveness ratios. The calculations of <a id="xref-fig-6-2" class="xref-fig" href="#F6">Table 4</a> and the curves of <a id="xref-fig-5-3" class="xref-fig" href="#F5">Fig. 2</a> allow medical teams to estimate cost-effectiveness ratios from cost data at their own institutions and to decide whether
                     they consider additional costs to be justified in view of the expected clinical benefits. When the comparator chosen for hepatic
                     arterial infusion is intravenous chemotherapy, the absence of a significant difference between both strategies (<a id="xref-ref-1-4" class="xref-bibr" href="#ref-1"><em>1</em></a>) makes it impossible to statistically rule out an infinite costeffectiveness ratio. If there were no true survival benefit
                     to hepatic arterial infusion compared with intravenous chemotherapy, this more costly procedure would clearly not be justified
                     on economic grounds. This observation justifies the use of a metaanalysis to estimate clinical benefits with sufficient precision
                     in pharmaco-economic assessments. It is now well known that patients with advanced colorectal cancer, even in the absence
                     of symptoms related to metastases, benefit from immediate intravenous chemotherapy. Immediate intravenous chemotherapy increases
                     symptom-free survival and overall survival (<a id="xref-ref-28-1" class="xref-bibr" href="#ref-28"><em>28</em></a>,<a id="xref-ref-29-1" class="xref-bibr" href="#ref-29"><em>29</em></a>). The cost-effectiveness ratio of hepatic arterial infusion compared strictly with intravenous chemotherapy is less favorable,
                     because the additional medical benefit of hepatic arterial infusion over intravenous chemotherapy is less than over symptom
                     palliation only.
                  </p>
                  
                  <p id="p-41">As far as the cost-effectiveness analyses are concerned, a few methodologic comments must be added. First, we used the intention-
                     to-treat principle throughout. As a result, patients who were randomly assigned to receive, but did not receive, hepatic arterial
                     infusion have been kept in this group for the estimation of both clinical benefits and costs. Likewise, we made no allowance
                     in our cost estimates for patients who received hepatic arterial infusion after intravenous chemotherapy had failed, although
                     crossover occurred for at least 20% of the patients in the trials (<a id="xref-ref-1-5" class="xref-bibr" href="#ref-1"><em>1</em></a>). This approach is voluntarily conservative and tends to increase the cost-effectiveness ratio of hepatic arterial infusion,
                     since it underestimates the true benefit of hepatic arterial infusion and underestimates the true cost of intravenous chemotherapy.
                  </p>
                  
                  <p id="p-42">The intravenous chemotherapy group of trials considered in the meta-analysis consisted of fluorouracil or 5-fluoro-2′- deoxyuridine
                     alone. Such therapy may no longer be considered standard practice in the treatment of advanced colorectal cancer. In three
                     previously performed meta-analyses, we showed that the modulation of intravenous fluorouracil by leucovorin or by methotrexate
                     (<a id="xref-ref-30-1" class="xref-bibr" href="#ref-30"><em>30</em></a>,<a id="xref-ref-31-1" class="xref-bibr" href="#ref-31"><em>31</em></a>) or the administration of fluorouracil by continuous infusion (Meta-Analysis Group In Cancer: unpublished data) resulted
                     in a doubling of the tumor response rates in patients with advanced colorectal cancer.
                  </p>
                  
                  <p id="p-43">However, these meta-analyses have also shown that the impact on survival of the modulation of fluorouracil or the administration
                     of fluorouracil as a continuous infusion was very small. Since our baseline analysis used survival as the principal outcome,
                     we do not think that the interpretation of the results of our study is invalidated by the development of these new modalities
                     of administration of fluorouracil.
                  </p>
                  
                  <p id="p-44">Prospective trials should ensure that information on both medical costs and overall financial costs to society be collected.
                     Other outcomes of interest that should be recorded prospectively include possible return to work of patients treated and their
                     quality of life.
                  </p>
                  
               </div>
               <div class="section fn-group" id="fn-group-1">
                  <div class="section-nav"><a href="#sec-12" title="Discussion" class="prev-section-link"><span>Previous Section</span></a><a href="#ref-list-1" title="References" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>Footnotes</h2>
                  <ul>
                     <li class="fn-supported-by" id="fn-1">
                        
                        <p id="p-1">Supported in part by the Association pour la Recherche contre le Cancer (France).</p>
                        
                        <p id="p-2"><strong>Collaborators of the Hepatic Arterial Infusion Meta-Analysis Project:</strong> P. Rougier, A. Laplanche, M. Huguier, and J. M. Hay (Groupe d'Etudes et de Recherches des Tumeurs Hépatiques and Association
                           Universitaire de Recherche en Chirurgie, Paris, France); R. Carlson, W. Brown, D. Hohn, and A. E. Venook (Northern California
                           Oncology Group, San Francisco, CA); T. G. Allen-Mersh and S. Earlam (Chelsea and Westminster Hospital, London, U.K.); N. E.
                           Kemeny and M. Mazumdar (Memorial Sloan-Kettering Cancer Center, New York, NY); M. J. O'Connell, S. Wieand, and K. Martin (Mayo
                           Clinic, Rochester, MN); A. E. Chang and V. K. Sondak (University of Michigan Medical Center, Ann Arbor); M. M. Kemeny (North
                           Shore University Hospital, Manhasset, NY); P. Piedbois, I. Durand-Zaleski, J.-P. Le Bourgeois, and Y. Piedbois (data management),
                           E. Levy and B. Roche (Henri Mondor Hospital, Paris); M. Buyse (International Institute for Drug Development, Brussels, Belgium).
                        </p>
                        
                        <p id="p-3"><strong>Board of the Meta-Analysis Group In Cancer:</strong> N. Wolmark (Allegheny Hospital, Pittsburgh, PA); P. Piedbois (Henri Mondor Hospital, Paris); M. Buyse (International Institute
                           for Drug Development, Brussels); R. Carlson (Stanford University, CA); Y. Rustum (Roswell Park Cancer Institute, Buffalo,
                           NY); C. E. Erlichman (Mayo Clinic).
                        </p>
                        
                        <p id="p-4">We are indebted to Dr. P.-P. Sagnier (Bayer AG, Wuppertal, Germany) and Dr. B. Hillner (Medical College of Virginia, Richmond)
                           for their helpful comments on the manuscript. We also thank Mr. B. Sullivan (Business Manager, Stanford Health Services, CA)
                           for his help in retrieving cost data.
                        </p>
                        
                     </li>
                  </ul>
               </div>
               <ul class="copyright-statement">
                  <li class="fn" id="copyright-statement-1">© Oxford University Press</li>
               </ul>
               <div class="section ref-list" id="ref-list-1">
                  <div class="section-nav"><a href="#fn-group-1" title="Footnotes" class="prev-section-link"><span>Previous Section</span></a><div class="nav-placeholder"> </div>
                  </div>
                  <h2>References</h2>
                  <ol class="cit-list ref-use-labels">
                     <li><span class="ref-label">(1)</span><a class="rev-xref-ref" href="#xref-ref-1-1" title="View reference (1) in text"
                           id="ref-1">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.11.790.1"
                             data-doi="10.1093/jnci/88.5.252">
                           <div class="cit-metadata"><cite><span class="cit-auth cit-collab">Meta-Analysis Group In Cancer</span>. <span class="cit-article-title">Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer</span>. <abbr class="cit-jnl-abbrev">J Natl Cancer Inst</abbr> <span class="cit-pub-date">1996</span>;<span class="cit-vol">88</span>:<span class="cit-fpage">252</span>-<span class="cit-lpage">8</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jnci&amp;resid=88/5/252"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(2)</span><a class="rev-xref-ref" href="#xref-ref-2-1" title="View reference (2) in text"
                           id="ref-2">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.11.790.2">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Chang</span>  <span class="cit-name-given-names">AE</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Schneider</span>  <span class="cit-name-given-names">PD</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Sugarbaker</span>  <span class="cit-name-given-names">PH</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Simpson</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Culane</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Steinberg</span>  <span class="cit-name-given-names">SM</span></span></li>
                              </ol><cite>. <span class="cit-article-title">A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of
                                    colorectal liver metastases</span>. <abbr class="cit-jnl-abbrev">Ann Surg</abbr> <span class="cit-pub-date">1987</span>;<span class="cit-vol">206</span>:<span class="cit-fpage">685</span>-<span class="cit-lpage">93</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=2961314&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1987L074700001&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=A%20prospective%20randomized%20trial%20of%20regional%20versus%20systemic%20continuous%205-fluorodeoxyuridine%20chemotherapy%20in%20the%20treatment%20of%20colorectal%20liver%20metastases&amp;author=AE%20Chang&amp;author=PD%20Schneider&amp;author=PH%20Sugarbaker&amp;author=C%20Simpson&amp;author=M%20Culane&amp;author=SM%20Steinberg&amp;publication_year=1987&amp;journal=Ann%20Surg&amp;volume=206&amp;pages=685-93">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(3)</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-89.11.790.3">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hohn</span>  <span class="cit-name-given-names">DC</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Stagg</span>  <span class="cit-name-given-names">RJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Friedman</span>  <span class="cit-name-given-names">MA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hannigan</span>  <span class="cit-name-given-names">JF</span>  <span class="cit-name-suffix">Jr</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rayner</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ignoffo</span>  <span class="cit-name-given-names">RJ</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic
                                    to the liver: the Northern California Oncology Group trial</span>. <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr> <span class="cit-pub-date">1989</span>;<span class="cit-vol">7</span>:<span class="cit-fpage">1646</span>-<span class="cit-lpage">54</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=7/11/1646"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(4)</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-89.11.790.4"
                             data-doi="10.1002/1097-0142(19860201)57:3&lt;492::AID-CNCR2820570315&gt;3.0.CO;2-M">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kemeny</span>  <span class="cit-name-given-names">MM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Goldberg</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Beatty</span>  <span class="cit-name-given-names">JD</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Blayney</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Browning</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Doroshow</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic
                                    metastases from colorectal primaries</span>. <abbr class="cit-jnl-abbrev">Cancer</abbr> <span class="cit-pub-date">1986</span>;<span class="cit-vol">57</span>:<span class="cit-fpage">492</span>-<span class="cit-lpage">8</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1002/1097-0142(19860201)57:3%3C492::AID-CNCR2820570315%3E3.0.CO;2-M&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=2935243&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Results%20of%20a%20prospective%20randomized%20trial%20of%20continuous%20regional%20chemotherapy%20and%20hepatic%20resection%20as%20treatment%20of%20hepatic%20metastases%20from%20colorectal%20primaries&amp;author=MM%20Kemeny&amp;author=D%20Goldberg&amp;author=JD%20Beatty&amp;author=D%20Blayney&amp;author=S%20Browning&amp;author=J%20Doroshow&amp;publication_year=1986&amp;journal=Cancer&amp;volume=57&amp;pages=492-8">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(5)</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-89.11.790.5"
                             data-doi="10.7326/0003-4819-107-4-459">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kemeny</span>  <span class="cit-name-given-names">N</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Daly</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Reichman</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Geller</span>  <span class="cit-name-given-names">N</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Botet</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Oderman</span>  <span class="cit-name-given-names">P</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized
                                    trial</span>. <abbr class="cit-jnl-abbrev">Ann Intern Med</abbr> <span class="cit-pub-date">1987</span>;<span class="cit-vol">107</span>:<span class="cit-fpage">459</span>-<span class="cit-lpage">65</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.7326/0003-4819-107-4-459&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=2957943&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1987K293000004&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Intrahepatic%20or%20systemic%20infusion%20of%20fluorodeoxyuridine%20in%20patients%20with%20liver%20metastases%20from%20colorectal%20carcinoma.%20A%20randomized%20trial&amp;author=N%20Kemeny&amp;author=J%20Daly&amp;author=B%20Reichman&amp;author=N%20Geller&amp;author=J%20Botet&amp;author=P%20Oderman&amp;publication_year=1987&amp;journal=Ann%20Intern%20Med&amp;volume=107&amp;pages=459-65">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(6)</span><a class="rev-xref-ref" href="#xref-ref-6-1" title="View reference (6) in text"
                           id="ref-6">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.11.790.6"
                             data-doi="10.1001/archsurg.1990.01410200086013">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Martin</span>  <span class="cit-name-given-names">JK</span>  <span class="cit-name-suffix">Jr</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">O#x0027;Connell</span>  <span class="cit-name-given-names">MJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Wieand</span>  <span class="cit-name-given-names">HS</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fitzgibbons</span>  <span class="cit-name-given-names">RJ</span>  <span class="cit-name-suffix">Jr</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Mailliard</span>  <span class="cit-name-given-names">JA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rubin</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial</span>. <abbr class="cit-jnl-abbrev">Arch Surg</abbr> <span class="cit-pub-date">1990</span>;<span class="cit-vol">125</span>:<span class="cit-fpage">1022</span>-<span class="cit-lpage">7</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1001/archsurg.1990.01410200086013&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=2143063&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1990DT47600012&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Intra-arterial%20floxuridine%20vs%20systemic%20fluorouracil%20for%20hepatic%20metastases%20from%20colorectal%20cancer.%20A%20randomized%20trial&amp;author=JK%20Martin&amp;author=MJ%20O%23x0027%3BConnell&amp;author=HS%20Wieand&amp;author=RJ%20Fitzgibbons&amp;author=JA%20Mailliard&amp;author=J%20Rubin&amp;publication_year=1990&amp;journal=Arch%20Surg&amp;volume=125&amp;pages=1022-7">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(7)</span><a class="rev-xref-ref" href="#xref-ref-7-1" title="View reference (7) in text"
                           id="ref-7">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.11.790.7">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rougier</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Laplanche</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Huguier</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hay</span>  <span class="cit-name-given-names">JM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ollivier</span>  <span class="cit-name-given-names">JM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Escat</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of
                                    a prospective randomized trial</span>. <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr> <span class="cit-pub-date">1992</span>;<span class="cit-vol">10</span>:<span class="cit-fpage">1112</span>-<span class="cit-lpage">8</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=10/7/1112"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(8)</span><a class="rev-xref-ref" href="#xref-ref-8-1" title="View reference (8) in text"
                           id="ref-8">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.11.790.8"
                             data-doi="10.1016/S0140-6736(94)90750-1">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Allen-Mersh</span>  <span class="cit-name-given-names">TG</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Earlam</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fordy</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Abrams</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Houghton</span>  <span class="cit-name-given-names">J</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases</span>. <abbr class="cit-jnl-abbrev">Lancet</abbr> <span class="cit-pub-date">1994</span>;<span class="cit-vol">344</span>:<span class="cit-fpage">1255</span>-<span class="cit-lpage">60</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S0140-6736(94)90750-1&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=7526096&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1994PP70100008&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Quality%20of%20life%20and%20survival%20with%20continuous%20hepatic-artery%20floxuridine%20infusion%20for%20colorectal%20liver%20metastases&amp;author=TG%20Allen-Mersh&amp;author=S%20Earlam&amp;author=C%20Fordy&amp;author=K%20Abrams&amp;author=J%20Houghton&amp;publication_year=1994&amp;journal=Lancet&amp;volume=344&amp;pages=1255-60">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(9)</span><a class="rev-xref-ref" href="#xref-ref-9-1" title="View reference (9) in text"
                           id="ref-9">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.11.790.9"
                             data-doi="10.1136/bmj.303.6803.595">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Allen-Mersh</span>  <span class="cit-name-given-names">TG</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Improving survival after large bowel cancer</span>. <abbr class="cit-jnl-abbrev">BMJ</abbr> <span class="cit-pub-date">1991</span>;<span class="cit-vol">303</span>:<span class="cit-fpage">595</span>-<span class="cit-lpage">6</span>. <span class="cit-comment">[editorial]</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=PDF&amp;journalCode=bmj&amp;resid=303/6803/595"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(10)</span><a class="rev-xref-ref" href="#xref-ref-10-1" title="View reference (10) in text"
                           id="ref-10">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.11.790.10"
                             data-doi="10.1093/jnci/88.5.223">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cole</span>  <span class="cit-name-given-names">BF</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Evaluating the clinical and economic trade-offs of hepatic arterial infusion</span>. <abbr class="cit-jnl-abbrev">J Natl Cancer Inst</abbr> <span class="cit-pub-date">1996</span>;<span class="cit-vol">88</span>:<span class="cit-fpage">223</span>-<span class="cit-lpage">4</span>. <span class="cit-comment">[editorial]</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=PDF&amp;journalCode=jnci&amp;resid=88/5/223"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(11)</span><a class="rev-xref-ref" href="#xref-ref-11-1" title="View reference (11) in text"
                           id="ref-11">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.11.790.11">
                           <div class="cit-metadata"><cite><span class="cit-article-title">Economic analysis of health care technology. A report on principles. Task Force on Principles for Economic Analysis of Health
                                    Care Technology</span>. <abbr class="cit-jnl-abbrev">Ann Intern Med</abbr> <span class="cit-pub-date">1995</span>;<span class="cit-vol">123</span>:<span class="cit-fpage">61</span>-<span class="cit-lpage">70</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=7762918&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1995RE66500012&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(12)</span>
                        
                        
                        <div class="cit ref-cit ref-book no-rev-xref" id="cit-89.11.790.12">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Drummond</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Stoddart</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Torrance</span>  <span class="cit-name-given-names">G</span></span></li>
                              </ol><cite>. <span class="cit-source">Methods for economic evaluation of health care programmes</span>. <span class="cit-publ-loc">Oxford</span>: <span class="cit-publ-name">Oxford University Press</span>; <span class="cit-pub-date">1989</span>. p. <span class="cit-fpage">18</span>-<span class="cit-lpage">34</span>, p. <span class="cit-fpage">74</span>-<span class="cit-lpage">83</span>.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Methods%20for%20economic%20evaluation%20of%20health%20care%20programmes&amp;author=M%20Drummond&amp;author=G%20Stoddart&amp;author=G%20Torrance&amp;publication_year=1989">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(13)</span><a class="rev-xref-ref" href="#xref-ref-13-1" title="View reference (13) in text"
                           id="ref-13">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.11.790.13">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Drummond</span>  <span class="cit-name-given-names">M</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Cost-effectiveness guidelines for reimbursement of pharmaceuticals: is economic evaluation ready for its enhanced status?</span> <abbr class="cit-jnl-abbrev">Health Econ</abbr> <span class="cit-pub-date">1992</span>;<span class="cit-vol">1</span>:<span class="cit-fpage">85</span>-<span class="cit-lpage">92</span>. <span class="cit-comment">[editorial]</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=1341931&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Cost-effectiveness%20guidelines%20for%20reimbursement%20of%20pharmaceuticals%3A%20is%20economic%20evaluation%20ready%20for%20its%20enhanced%20status%3F&amp;author=M%20Drummond&amp;publication_year=1992&amp;journal=Health%20Econ&amp;volume=1&amp;pages=85-92">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(14)</span><a class="rev-xref-ref" href="#xref-ref-14-1" title="View reference (14) in text"
                           id="ref-14">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.11.790.14"
                             data-doi="10.1016/S0140-6736(94)92274-8">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Sculpher</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Henderson</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Buxton</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pocok</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Parker</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Joy</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Health service costs of coronary angioplasty bypass surgery: the Randomized Intervention Treatment of Angina (RITA) Trial</span>. <abbr class="cit-jnl-abbrev">Lancet</abbr> <span class="cit-pub-date">1994</span>;<span class="cit-vol">344</span>:<span class="cit-fpage">927</span>-<span class="cit-lpage">30</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S0140-6736(94)92274-8&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=7934351&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1994PJ28700015&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Health%20service%20costs%20of%20coronary%20angioplasty%20bypass%20surgery%3A%20the%20Randomized%20Intervention%20Treatment%20of%20Angina%20%28RITA%29%20Trial&amp;author=M%20Sculpher&amp;author=R%20Henderson&amp;author=M%20Buxton&amp;author=S%20Pocok&amp;author=J%20Parker&amp;author=M%20Joy&amp;publication_year=1994&amp;journal=Lancet&amp;volume=344&amp;pages=927-30">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(15)</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-89.11.790.15"
                             data-doi="10.7326/0003-4819-119-11-199312010-00008">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Anderson</span>  <span class="cit-name-given-names">DR</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">O'Brien</span>  <span class="cit-name-given-names">BJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Levine</span>  <span class="cit-name-given-names">MN</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Roberts</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Wells</span>  <span class="cit-name-given-names">PS</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hirsh</span>  <span class="cit-name-given-names">J</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Efficacy and cost of low-molecular-weight heparin compared with standard heparin for the prevention of deep vein thrombosis
                                    after total hip arthroplasty</span>. <abbr class="cit-jnl-abbrev">Ann Intern Med</abbr> <span class="cit-pub-date">1993</span>;<span class="cit-vol">119</span>:<span class="cit-fpage">1105</span>-<span class="cit-lpage">12</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.7326/0003-4819-119-11-199312010-00008&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=8239230&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1993MJ33500008&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Efficacy%20and%20cost%20of%20low-molecular-weight%20heparin%20compared%20with%20standard%20heparin%20for%20the%20prevention%20of%20deep%20vein%20thrombosis%20after%20total%20hip%20arthroplasty&amp;author=DR%20Anderson&amp;author=BJ%20O%27Brien&amp;author=MN%20Levine&amp;author=R%20Roberts&amp;author=PS%20Wells&amp;author=J%20Hirsh&amp;publication_year=1993&amp;journal=Ann%20Intern%20Med&amp;volume=119&amp;pages=1105-12">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(16)</span><a class="rev-xref-ref" href="#xref-ref-16-1" title="View reference (16) in text"
                           id="ref-16">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.11.790.16"
                             data-doi="10.1177/0272989X9401400203">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Midgette</span>  <span class="cit-name-given-names">AS</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Wong</span>  <span class="cit-name-given-names">JB</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Beshansky</span>  <span class="cit-name-given-names">JR</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Porath</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fleming</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pauker</span>  <span class="cit-name-given-names">SG</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Cost-effectiveness of streptokinase for acute myocardial infarction: a combined meta-analysis and decision making of the effects
                                    of infarct location and of likelihood of infarction</span>. <abbr class="cit-jnl-abbrev">Med Decis Making</abbr> <span class="cit-pub-date">1994</span>;<span class="cit-vol">14</span>:<span class="cit-fpage">108</span>-<span class="cit-lpage">17</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=spmdm&amp;resid=14/2/108"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(17)</span><a class="rev-xref-ref" href="#xref-ref-17-1" title="View reference (17) in text"
                           id="ref-17">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.11.790.17"
                             data-doi="10.1136/bmj.307.6907.793">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Robinson</span>  <span class="cit-name-given-names">R</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Cost-effectiveness analysis</span>. <abbr class="cit-jnl-abbrev">BMJ</abbr> <span class="cit-pub-date">1993</span>;<span class="cit-vol">307</span>:<span class="cit-fpage">793</span>-<span class="cit-lpage">5</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=bmj&amp;resid=307/6907/793"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(18)</span><a class="rev-xref-ref" href="#xref-ref-18-1" title="View reference (18) in text"
                           id="ref-18">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.11.790.18"
                             data-doi="10.1136/bmj.307.6905.670">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Robinson</span>  <span class="cit-name-given-names">R</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Economic evaluation and health care. What does it mean?</span> <abbr class="cit-jnl-abbrev">BMJ</abbr> <span class="cit-pub-date">1993</span>;<span class="cit-vol">307</span>:<span class="cit-fpage">670</span>-<span class="cit-lpage">3</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=bmj&amp;resid=307/6905/670"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(19)</span><a class="rev-xref-ref" href="#xref-ref-19-1" title="View reference (19) in text"
                           id="ref-19">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.11.790.19"
                             data-doi="10.1093/jnci/87.6.417">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Taplin</span>  <span class="cit-name-given-names">SH</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Barlow</span>  <span class="cit-name-given-names">W</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Urban</span>  <span class="cit-name-given-names">N</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Mandelson</span>  <span class="cit-name-given-names">MT</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Timlin</span>  <span class="cit-name-given-names">DJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ichikawa</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care</span>. <abbr class="cit-jnl-abbrev">J Natl Cancer Inst</abbr> <span class="cit-pub-date">1995</span>;<span class="cit-vol">87</span>:<span class="cit-fpage">417</span>-<span class="cit-lpage">26</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jnci&amp;resid=87/6/417"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(20)</span><a class="rev-xref-ref" href="#xref-ref-20-1" title="View reference (20) in text"
                           id="ref-20">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.11.790.20">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Findlay</span>  <span class="cit-name-given-names">M</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Cost analysis of palliative chemotherapy for patients with gastrointestinal malignancy</span>. <abbr class="cit-jnl-abbrev">Ann Oncol</abbr> <span class="cit-pub-date">1995</span>;<span class="cit-vol">6</span>:<span class="cit-fpage">205</span>-<span class="cit-lpage">7</span>. <span class="cit-comment">[editorial]</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=PDF&amp;journalCode=annonc&amp;resid=6/3/205"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(21)</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-89.11.790.21"
                             data-doi="10.1093/jnci/85.18.1460">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Smith</span>  <span class="cit-name-given-names">TJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hillner</span>  <span class="cit-name-given-names">BE</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Desch</span>  <span class="cit-name-given-names">CE</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Efficacy and cost-effectiveness of cancer treatment: rational allocation of resources based on decision analysis</span>. <abbr class="cit-jnl-abbrev">J Natl Cancer Inst</abbr> <span class="cit-pub-date">1993</span>;<span class="cit-vol">85</span>:<span class="cit-fpage">1460</span>-<span class="cit-lpage">74</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=PDF&amp;journalCode=jnci&amp;resid=85/18/1460"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(22)</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-89.11.790.22"
                             data-doi="10.1001/jama.1992.03480150061038">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hillner</span>  <span class="cit-name-given-names">BE</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Smith</span>  <span class="cit-name-given-names">TJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Desch</span>  <span class="cit-name-given-names">CE</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Efficacy and cost-effectiveness of autologous bone marrow transplantation in metastatic breast cancer. Estimates using decision
                                    analysis while awaiting clinical trial results</span>. <abbr class="cit-jnl-abbrev">JAMA</abbr> <span class="cit-pub-date">1992</span>;<span class="cit-vol">267</span>:<span class="cit-fpage">2055</span>-<span class="cit-lpage">61</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1001/jama.1992.03480150061038&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=1552641&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1992HM65000031&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Efficacy%20and%20cost-effectiveness%20of%20autologous%20bone%20marrow%20transplantation%20in%20metastatic%20breast%20cancer.%20Estimates%20using%20decision%20analysis%20while%20awaiting%20clinical%20trial%20results&amp;author=BE%20Hillner&amp;author=TJ%20Smith&amp;author=CE%20Desch&amp;publication_year=1992&amp;journal=JAMA&amp;volume=267&amp;pages=2055-61">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(23)</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-89.11.790.23">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Jonsson</span>  <span class="cit-name-given-names">E</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Economics in clinical cancer research: methodology and assessment</span>. <abbr class="cit-jnl-abbrev">Biomed Pharmacother</abbr> <span class="cit-pub-date">1988</span>;<span class="cit-vol">42</span>:<span class="cit-fpage">645</span>-<span class="cit-lpage">52</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=3148337&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1988T228000006&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Economics%20in%20clinical%20cancer%20research%3A%20methodology%20and%20assessment&amp;author=E%20Jonsson&amp;publication_year=1988&amp;journal=Biomed%20Pharmacother&amp;volume=42&amp;pages=645-52">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(24)</span><a class="rev-xref-ref" href="#xref-ref-24-1" title="View reference (24) in text"
                           id="ref-24">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.11.790.24">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Glimelius</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hoffman</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Graf</span>  <span class="cit-name-given-names">W</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Haglund</span>  <span class="cit-name-given-names">U</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Nyren</span>  <span class="cit-name-given-names">O</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pahlman</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer</span>. <abbr class="cit-jnl-abbrev">Ann Oncol</abbr> <span class="cit-pub-date">1995</span>;<span class="cit-vol">6</span>:<span class="cit-fpage">267</span>-<span class="cit-lpage">74</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=annonc&amp;resid=6/3/267"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(25)</span><a class="rev-xref-ref" href="#xref-ref-25-1" title="View reference (25) in text"
                           id="ref-25">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.11.790.25">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Laupacis</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Feeny</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Detsky</span>  <span class="cit-name-given-names">AS</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tugwell</span>  <span class="cit-name-given-names">PX</span></span></li>
                              </ol><cite>. <span class="cit-article-title">How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical
                                    and economic evaluations</span>. <abbr class="cit-jnl-abbrev">Can Med Assoc J</abbr> <span class="cit-pub-date">1992</span>;<span class="cit-vol">146</span>:<span class="cit-fpage">473</span>-<span class="cit-lpage">81</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=cmaj&amp;resid=146/4/473"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(26)</span><a class="rev-xref-ref" href="#xref-ref-26-1" title="View reference (26) in text"
                           id="ref-26">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.11.790.26">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Zanon</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Grosso</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Zanon</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Veltri</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Alabiso</span>  <span class="cit-name-given-names">O</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bazzan</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Transaxillary access to effect local-regional chemotherapy with hepatic artery infusion (hepatic arterial infusion) for secondary
                                    or primitive hepatic tumors</span>. <abbr class="cit-jnl-abbrev">Ann Oncol</abbr> <span class="cit-pub-date">1996</span>;(<span class="cit-issue">(7 Suppl)</span>):<span class="cit-fpage">52</span>. <span class="cit-comment">[abstract]</span>.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Transaxillary%20access%20to%20effect%20local-regional%20chemotherapy%20with%20hepatic%20artery%20infusion%20%28hepatic%20arterial%20infusion%29%20for%20secondary%20or%20primitive%20hepatic%20tumors&amp;author=C%20Zanon&amp;author=M%20Grosso&amp;author=E%20Zanon&amp;author=A%20Veltri&amp;author=O%20Alabiso&amp;author=M%20Bazzan&amp;publication_year=1996&amp;journal=Ann%20Oncol&amp;issue=%287%20Suppl%29&amp;pages=52">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(27)</span><a class="rev-xref-ref" href="#xref-ref-27-1" title="View reference (27) in text"
                           id="ref-27">↵</a>
                        
                        
                        <div class="cit ref-cit ref-book" id="cit-89.11.790.27">
                           <div class="cit-metadata"><cite><span class="cit-source">A review of seventeen countries</span>. <span class="cit-publ-loc">Paris</span>: <span class="cit-publ-name">OECD Publications</span>; <span class="cit-pub-date">1994</span>. <span class="cit-article-title">The reform of healthcare systems</span>.</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(28)</span><a class="rev-xref-ref" href="#xref-ref-28-1" title="View reference (28) in text"
                           id="ref-28">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.11.790.28"
                             data-doi="10.1136/bmj.306.6880.752">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Scheithauer</span>  <span class="cit-name-given-names">W</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rosen</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kornek</span>  <span class="cit-name-given-names">GV</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Sebesta</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Depisch</span>  <span class="cit-name-given-names">D</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic
                                    colorectal cancer</span>. <abbr class="cit-jnl-abbrev">BMJ</abbr> <span class="cit-pub-date">1993</span>;<span class="cit-vol">306</span>:<span class="cit-fpage">752</span>-<span class="cit-lpage">5</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=bmj&amp;resid=306/6880/752"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(29)</span><a class="rev-xref-ref" href="#xref-ref-29-1" title="View reference (29) in text"
                           id="ref-29">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.11.790.29">
                           <div class="cit-metadata"><cite><span class="cit-auth cit-collab">Nordic Gastrointestinal Tumor Adjuvant Therapy Group</span>. <span class="cit-article-title">Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial</span>. <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr> <span class="cit-pub-date">1992</span>;<span class="cit-vol">10</span>:<span class="cit-fpage">904</span>-<span class="cit-lpage">11</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=10/6/904"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(30)</span><a class="rev-xref-ref" href="#xref-ref-30-1" title="View reference (30) in text"
                           id="ref-30">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.11.790.30">
                           <div class="cit-metadata"><cite><span class="cit-article-title">Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate.
                                    Advanced olorectal Cancer Meta-Analysis Project</span>. <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr> <span class="cit-pub-date">1992</span>;<span class="cit-vol">10</span>:<span class="cit-fpage">896</span>-<span class="cit-lpage">903</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=10/6/896"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(31)</span><a class="rev-xref-ref" href="#xref-ref-31-1" title="View reference (31) in text"
                           id="ref-31">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.11.790.31">
                           <div class="cit-metadata"><cite><span class="cit-article-title">Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal
                                    cancer. Advanced Colorectal Cancer Meta-Analysis Project</span>. <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr> <span class="cit-pub-date">1994</span>;<span class="cit-vol">12</span>:<span class="cit-fpage">960</span>-<span class="cit-lpage">9</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=12/5/960"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                  </ol>
               </div><span class="highwire-journal-article-marker-end"></span></div><span id="related-urls"></span></div>
         <div id="col-2">
            
            <div class="article-nav sidebar-nav">
               <a href="/content/89/11/783.short" title="Previous article" class="previous">« Previous</a><span class="article-nav-sep"> | </span><a href="/content/89/11/796.short" title="Next article" class="next">Next Article »</a>
               
               <span class="toc-link">
                  				<a href="/content/89/11.toc" title="Table of Contents">Table of Contents</a>
                  			</span>
               
               
            </div>
            <div class="content-box" id="article-cb-main">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>This Article</span></h3>
                  <div class="cb-section cb-slug">
                     <ol>
                        <li>
                           <div id="slugline">
                              
                              <cite>
                                 <abbr title="JNCI Journal of the National Cancer Institute" class="slug-jnl-abbrev">
                                    <nlm:abbrev-journal-title xmlns:nlm="http://schema.highwire.org/NLM/Journal" abbrev-type="publisher">JNCI J Natl Cancer Inst</nlm:abbrev-journal-title></abbr><span class="slug-pub-date" itemprop="datePublished">
                                    (1997) 
                                    </span>
                                 
                                 <span class="slug-vol">
                                    89
                                    </span><span class="slug-issue">
                                    (11):
                                    </span><span class="slug-pages">
                                    790-795.
                                    </span>
                                 <span class="slug-doi-wrapper">
                                    
                                    doi:
                                    
                                    <span title="10.1093/jnci/89.11.790" class="slug-doi">10.1093/jnci/89.11.790</span>
                                    </span>
                                 </cite>
                              
                              
                              
                              
                              
                              
                              
                              
                              
                              
                              
                              
                           </div>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section cb-views">
                     <ol>
                        <li class="abstract-view-link primary"><a href="/content/89/11/790.abstract" rel="view-abstract">Abstract</a><span class="free">Free</span></li>
                        <li class="notice full-text-view-link"><span class="variant-indicator">» <span>Full Text (HTML)</span></span><span class="free">Free</span></li>
                        <li class="notice full-text-pdf-view-link"><a href="/content/89/11/790.full.pdf+html" rel="view-full-text.pdf">Full Text (PDF)</a><span class="free">Free</span></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-cat">
                     <h4 class="cb-section-header"><span>Classifications</span></h4>
                     <ol>
                        <li>
                           <ul class="subject-headings last-child">
                              <li><a class="tocsection-search"
                                    href="/search?tocsectionid=Articles&amp;sortspec=date&amp;submit=Submit">Article</a></li>
                           </ul>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-svcs">
                     <h4 class="cb-section-header"><span>Services</span></h4>
                     <ol>
                        <li class="usage-stats-link icon-link"><a href="/articleusage?gca=jnci;89/11/790" rel="nofollow">Article metrics</a></li>
                        <li class="alert-link icon-link"><a href="/cgi/alerts/ctalert?alertType=citedby&amp;addAlert=cited_by&amp;cited_by_criteria_resid=jnci%3B89%2F11%2F790&amp;saveAlert=no&amp;return-type=article&amp;return_url=http://jnci.oxfordjournals.org/content/89/11/790.full">Alert me when cited</a></li>
                        <li class="alert-link icon-link"><a href="/cgi/alerts/ctalert?alertType=correction&amp;addAlert=correction&amp;correction_criteria_value=89/11/790&amp;saveAlert=no&amp;return-type=article&amp;return_url=http://jnci.oxfordjournals.org/content/89/11/790.full">Alert me if corrected</a></li>
                        <li class="similar-link"><a href="/search?qbe=jnci%3B89.11.790&amp;citation=Durand-Zaleski%20et%20al.%2089%20%2811%29:%20790&amp;submit=yes">Find similar articles</a></li>
                        <li class="similar-link"><a href="/external-ref?access_num=jnci%3B89%2F11%2F790&amp;link_type=ISI_RELATEDRECORDS"
                              id="cb-isi-similar-articles"
                              class="similar-link">Similar articles in Web of Science</a></li>
                        <li class="similar-link"><a href="/external-ref?access_num=9182977&amp;link_type=MED_NBRS" class="similar-link">Similar articles in PubMed</a></li>
                        <li class="folder-link icon-link"><a href="/cgi/folders?action=addtofolder&amp;wherefrom=JOURNALS&amp;wrapped_id=jnci%3B89%2F11%2F790">Add to my archive</a></li>
                        <li class="cit-man-link icon-link cite-link"><a href="/citmgr?gca=jnci%3B89%2F11%2F790">Download citation</a></li>
                        <li><a class="request-permissions"
                              href="https://s100.copyright.com/AppDispatchServlet?publisherName=oup&amp;publication=jnci&amp;title=Economic%20Implications%20of%20Hepatic%20Arterial%20Infusion%20Chemotherapy%20in%20Treatment%20of%20Nonresectable%20Colorectal%20Liver%20Metastases%3A%20&amp;publicationDate=06%2F04%2F1997&amp;author=Isabelle%20Durand-Zaleski%2C%20B%C3%A9atrice%20Roche%2C%20Pierre-Louis%20Fagniez%2C%20Jean-Paul%20Le%20Bourgeois%2C%20Pascal%20Piedbois%2C%20Marc%20Buyse%2C%20Robert%20Carlson%2C%20Michael%20J.%20O%27Conell%2C%20Philippe%20Rougier%2C%20Alfred%20E.%20Chang%2C%20Vernon%20K.%20Sondak%2C%20Margaret%20M.%20Kemeny%2C%20Tim%20G.%20Allen-Mersh&amp;copyright=Oxford%20University%20Press&amp;contentID=10.1093%2Fjnci%2F89.11.790&amp;volumeNum=89&amp;issueNum=11&amp;startPage=790&amp;endPage=795&amp;orderBeanReset=true"
                              target="_blank">Request Permissions</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-cit">
                     <h4 class="cb-section-header"><span>Citing Articles</span></h4>
                     <ol>
                        <li class="hw-citing-link"><a href="/content/89/11/790.full?cited-by=yes&amp;legid=jnci;89/11/790#cited-by"
                              id="cb-hw-citing-articles">Load citing article information</a></li>
                        <li><a href="/cgi/crossref-forward-links/89/11/790" rel="external-nw"
                              id="cb-crossref-citing-articles">Citing articles via CrossRef</a></li>
                        <li><a href="/scopus-links/jnci/89/11/790?access_num=/jnci/89/11/790"
                              rel="external-nw"
                              id="cb-scopus-citing-articles">Citing articles via Scopus</a></li>
                        <li><a href="/external-ref?access_num=%2Fjnci%2F89%2F11%2F790&amp;link_type=ISI_CITING&amp;accnum_type=native"
                              rel="external-nw"
                              id="cb-isi-citing-articles">Citing articles via Web of Science</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-gs">
                     <h4 class="cb-section-header"><span>Google Scholar</span></h4>
                     <ol>
                        <li class="cb-art-gs-auth author-link"><a href="http://scholar.google.com/scholar?q=%22author%3ADurand-Zaleski%20author%3AI.%22"
                              class="cb-art-gs-auth author-link">Articles by  Durand-Zaleski, I.</a></li>
                        <li class="cb-art-gs-auth author-link"><a href="http://scholar.google.com/scholar?q=%22author%3AAllen-Mersh%20author%3AT.G.%22"
                              class="cb-art-gs-auth author-link">Articles by  Allen-Mersh, T. G.</a></li>
                        <li class="cb-art-gs-rel similar-link"><a href="/external-ref?access_num=http://jnci.oxfordjournals.org/content/89/11/790.abstract&amp;link_type=GOOGLESCHOLARRELATED">Search for related content</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-pm">
                     <h4 class="cb-section-header"><span>PubMed</span></h4>
                     <ol>
                        <li class="cb-art-pm-cite cite-link icon-link"><a href="/external-ref?access_num=9182977&amp;link_type=PUBMED"
                              class="cb-art-pm-cite cite-link icon-link">PubMed citation</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Durand-Zaleski%20I&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Durand-Zaleski, I.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Roche%20B&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Roche, B.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Fagniez%20PL&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Fagniez, P. L.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Le%20Bourgeois%20JP&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Le Bourgeois, J. P.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Piedbois%20P&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Piedbois, P.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Buyse%20M&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Buyse, M.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Carlson%20R&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Carlson, R.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=O%27Conell%20MJ&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  O'Conell, M. J.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Rougier%20P&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Rougier, P.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Chang%20AE&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Chang, A. E.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Sondak%20VK&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Sondak, V. K.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Kemeny%20MM&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Kemeny, M. M.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Allen-Mersh%20TG&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Allen-Mersh, T. G.</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-rel">
                     <h4 class="cb-section-header"><span>Related Content</span></h4>
                     <ol>
                        <li><a href="/content/89/11/790.full?related-urls=yes&amp;legid=jnci;89/11/790#related-urls"
                              id="cb-related-urls">Load related web page information</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-soc">
                     <h4 class="cb-section-header"><span>Share</span></h4>
                     <ol>
                        <li><a href="/email?gca=jnci%3B89%2F11%2F790&amp;current-view-path=/content/89/11/790.full">
                              Email this article</a></li>
                        <li>
                           <div class="social-bookmarking">
                              
                              <ul class="social-bookmark-links">
                                 <li class="social-bookmarking-item social-bookmarking-item-citeulike"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/89/11/790&amp;title=Economic%20Implications%20of%20Hepatic%20Arterial%20Infusion%20Chemotherapy%20in%20Treatment%20of%20Nonresectable%20Colorectal%20Liver%20Metastases+--+Durand-Zaleski%20et%20al.%2089%20%2811%29%3A%20790+--+jnci&amp;doi=10.1093/jnci/89.11.790&amp;link_type=CITEULIKE"><img src="/shared/img/common/social-bookmarking/citeulike.gif"
                                            alt="Add to CiteULike"
                                            title="CiteULike" /></a><span class="soc-bm-link-text">CiteULike</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-delicious"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/89/11/790&amp;title=Economic%20Implications%20of%20Hepatic%20Arterial%20Infusion%20Chemotherapy%20in%20Treatment%20of%20Nonresectable%20Colorectal%20Liver%20Metastases+--+Durand-Zaleski%20et%20al.%2089%20%2811%29%3A%20790+--+jnci&amp;doi=10.1093/jnci/89.11.790&amp;link_type=DEL_ICIO_US"><img src="/shared/img/common/social-bookmarking/delicious.gif"
                                            alt="Add to Delicious"
                                            title="Delicious" /></a><span class="soc-bm-link-text">Delicious</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-facebook"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/short/89/11/790&amp;title=Economic%20Implications%20of%20Hepatic%20Arterial%20Infusion%20Chemotherapy%20in%20Treatment%20of%20Nonresectable%20Colorectal%20Liver%20Metastases+--+Durand-Zaleski%20et%20al.%2089%20%2811%29%3A%20790+--+jnci&amp;doi=10.1093/jnci/89.11.790&amp;link_type=FACEBOOK"
                                       class="sb-facebook"
                                       rel="external-nw"><img src="/shared/img/common/social-bookmarking/facebook.gif" alt="Add to Facebook"
                                            title="Facebook" /></a><span class="soc-bm-link-text">Facebook</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-googleplus"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/89/11/790&amp;title=Economic%20Implications%20of%20Hepatic%20Arterial%20Infusion%20Chemotherapy%20in%20Treatment%20of%20Nonresectable%20Colorectal%20Liver%20Metastases+--+Durand-Zaleski%20et%20al.%2089%20%2811%29%3A%20790+--+jnci&amp;doi=10.1093/jnci/89.11.790&amp;link_type=GOOGLEPLUS&amp;log_only=yes"><img src="/shared/img/common/social-bookmarking/googleplus.jpg" alt="Add to Google+"
                                            title="Google+" /></a><span class="soc-bm-link-text">Google+</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-mendeley"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/89/11/790&amp;title=Economic%20Implications%20of%20Hepatic%20Arterial%20Infusion%20Chemotherapy%20in%20Treatment%20of%20Nonresectable%20Colorectal%20Liver%20Metastases+--+Durand-Zaleski%20et%20al.%2089%20%2811%29%3A%20790+--+jnci&amp;doi=10.1093/jnci/89.11.790&amp;link_type=MENDELEY"><img src="/shared/img/common/social-bookmarking/mendeley.gif" alt="Add to Mendeley"
                                            title="Mendeley" /></a><span class="soc-bm-link-text">Mendeley</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-twitter"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/89/11/790&amp;title=Economic%20Implications%20of%20Hepatic%20Arterial%20Infusion%20Chemotherapy%20in%20Treatment%20of%20Nonresectable%20Colorectal%20Liver%20Metastases+--+Durand-Zaleski%20et%20al.%2089%20%2811%29%3A%20790+--+jnci&amp;doi=10.1093/jnci/89.11.790&amp;link_type=TWITTER"><img src="/shared/img/common/social-bookmarking/twitter.gif" alt="Add to Twitter"
                                            title="Twitter" /></a><span class="soc-bm-link-text">Twitter</span></li>
                              </ul>
                              
                              <p class="social-bookmarking-help"><a href="/help/social_bookmarks.dtl">What's this?</a></p>
                              
                           </div>
                        </li>
                     </ol>
                  </div>
               </div>
            </div>
            
            
            <div class="content-box" id="article-dyn-nav">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>Navigate This Article</span></h3>
                  <div class="cb-section" id="cb-art-nav">
                     <ol>
                        <li><a href="#content-block">Top</a></li>
                        <li><a href="#abstract-1">Abstract</a></li>
                        <li><a href="#sec-1">Subjects and Methods</a></li>
                        <li><a href="#sec-7">Results</a></li>
                        <li><a href="#sec-12">Discussion</a></li>
                        <li><a href="#fn-group-1">Footnotes</a></li>
                        <li><a href="#ref-list-1">References</a></li>
                     </ol>
                  </div>
               </div>
            </div>
            
         </div>
         <div id="col-3">
            
            <div id="col-3-qs" class="sidebar-qs">
               
               
               <form class="searchbox" action="/search" method="get">
                  <p>Search this journal:</p>
                  <div>
                     	
                     	
                     	<input value="" type="text" name="fulltext" id="header-qs-input" />
                     <input type="hidden" name="submit" value="yes" />
                     
                     <input class="inline_button" type="image" alt="Go" src="/publisher/img/buttons/go.gif" />
                     
                     <div class="adv-search-link"><a href="/search">Advanced »</a></div>
                     
                     
                  </div>
               </form>
               
            </div>
            <div class="cb-contents">
               
               <div id="sidebar-current-issue" class="content-box">
                  	
                  <h3 class="cb-contents-header">Current Issue</h3>
                  	
                  <div class="cb-section">
                     	  
                     <ol>
                        <li>
                           	      <a href="/content/current"><span>
                                 		  <span class="current-issue-date">
                                    October 2015
                                    </span><span class="toc-citation-volume">
                                    
                                    107
                                    </span><span class="toc-citation-issue">(10)</span>
                                 		  
                                 		</span></a>
                           	    
                        </li>
                     </ol>
                     	
                  </div>
                  	
                  <div class="cb-section">
                     	  
                     <ol>
                        <li>
                           <a href="/content/current"><img src="/content/107/10.cover.gif" alt="JNCI J Natl Cancer Inst" id="cover" /></a>
                           
                        </li>
                     </ol>
                     	
                  </div>
                  	
                  <div class="cb-section sidebar-etoc-link">
                     	  
                     <ol>
                        <li><a href="/cgi/alerts/etoc">Alert me to new issues</a></li>
                     </ol>
                     	
                  </div>
                  
               </div>
               
            </div>
            
            <div id="second">
               
               <div class="ad_hidden" id="oas_right1">
                  <iframe id="id_advertframe_right1"
                          src="/resource/htmlfiles/advert.html?p=Right1&amp;u=jnci.oxfordjournals.org/content/89/11/790.full"
                          width="0"
                          height="0"
                          frameborder="0"
                          scrolling="no"
                          class="resize_ad"></iframe>
                  
               </div>
               
               <div class="features">
                  
                  <div class="feature separator_after first">
                     
                     <h2 id="the_journal" title="The Journal"><span>The Journal</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/about.html" rel=""
                              title="About this journal">About this journal</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/contact_us.html" rel=""
                              title="Contact Us">Contact Us</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/access_purchase/rights_permissions.html"
                              rel=""
                              title="Rights &amp; Permissions">Rights &amp; Permissions</a>
                           
                        </li>
                        <li>
                           <a href="HTTP://www.oxfordjournals.org/access_purchase/dispatch_dates.html#JNCI.JP"
                              rel=""
                              title="Dispatch date of next issue">Dispatch date of next issue</a>
                           
                        </li>
                        <li>
                           <a href="http://publicationethics.org/" rel=""
                              title="This journal is a member of the Committee on Publication Ethics (COPE)">This journal is a member of the Committee on Publication Ethics (COPE)</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/mobile_faqs.html" rel=""
                              title="We are mobile – find out more">We are mobile – find out more</a>
                           
                        </li>
                        <li>
                           <a href="http://medicine-and-health-careernetwork.oxfordjournals.org/jobseeker/search/results/?t730=&amp;t732=469986&amp;t731=&amp;t733=&amp;t735=&amp;t737=&amp;max=25&amp;site_id=20102"
                              rel=""
                              title="Journals Career Network">Journals Career Network</a>
                           
                        </li>
                     </ul>
                     
                     <p>
                        <a href="http://www.oxfordjournals.org/our_journals/jnci/episodes_2012.html">
                           <img alt="Podcast Logo" style="float:left"
                                src="http://www.oxfordjournals.org/podcasts/podcast_icon_35x35.gif" />JNCI Podcast</a>
                        <br />
                        <br />
                        
                     </p>
                     
                  </div>
                  
                  <div class="feature separator_after">
                     
                     <h3>Connect with us!</h3>
                     <a href="https://twitter.com/JNCI_Now">
                        <img class="small_margin" alt="Connect with us on Twitter!"
                             src="http://www.oxfordjournals.org/our_journals/phisci/connect_twitter.png"
                             style="vertical-align: top; float: left; " />
                        </a>
                     <a href="https://www.facebook.com/thejnci">
                        <img class="small_margin" alt="Connect with us on Facebook!"
                             src="http://www.oxfordjournals.org/our_journals/phisci/facebook.png"
                             style="vertical-align: top; float: left; " />
                        </a>
                     
                     <p>
                        <br />
                        <br />
                        
                     </p>
                     
                  </div>
                  
                  <div class="feature separator_after">
                     
                     <h3>Editor-in-Chief</h3>
                     
                     <p>Carmen J. Allegra</p>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/editorial_board.html"
                              rel=""
                              title="View full editorial board">View full editorial board</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature separator_after">
                     
                     <h3>Impact factor: 12.583</h3>
                     
                     <h3 class="five_year">5-Yr impact factor: 13.584</h3>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h3>For the Media</h3>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/press_room.html" rel=""
                              title="JNCI PRESS ROOM">JNCI PRESS ROOM</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h2 id="for_authors" title="For Authors"><span>For Authors</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/for_authors/index.html"
                              rel=""
                              title="Instructions to authors">Instructions to authors</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/access_purchase/self-archiving_policyb.html"
                              rel=""
                              title="Self Archiving/Public Access Policy">Self Archiving/Public Access Policy</a>
                           
                        </li>
                     </ul>
                     <a href="http://www.oxfordjournals.org/oxfordopen/ ">
                        <img alt="Open access options for authors - visit Oxford Open"
                             src="http://www.oxfordjournals.org/resource/image/promos/oxford_open_small.gif" />
                        </a>
                     <a href="http://www.oxfordjournals.org/oxfordopen/funder_policies/">
                        <img alt="RCUK Wellcome Trust Open Access"
                             src="http://www.oxfordjournals.org/resource/image/wellcome-trust-180x100.jpg" />
                        </a>
                     
                     <p>Open access options for authors - visit <a href="http://www.oxfordjournals.org/oxfordopen/">Oxford Open</a>
                        
                     </p>
                     <a href="http://publicaccess.nih.gov/submit_process_journals.htm">
                        <img alt="PMC Logo" src="http://www.oxfordjournals.org/resource/image/pmc-logo.gif" />
                        </a>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://publicaccess.nih.gov/submit_process_journals.htm" rel=""
                              title="This journal enables compliance with the NIH Public Access Policy">This journal enables compliance with the NIH Public Access Policy</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h2 id="alerting_services" title="Alerting Services"><span>Alerting Services</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="/cgi/alerts/etoc" rel="" title="Email table of contents">Email table of contents</a>
                           
                        </li>
                        <li>
                           <a href="/cgi/alerts/etoc" rel="" title="Email Advance Access">Email Advance Access</a>
                           
                        </li>
                        <li>
                           <a href="http://jnci.oxfordjournals.org/help/citetrack/index.dtl" rel=""
                              title="CiteTrack">CiteTrack</a>
                           
                        </li>
                        <li>
                           <a href="/rss" rel="" title="XML RSS feed">XML RSS feed</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h2 id="corporate_services" title="Corporate Services"><span>Corporate Services</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/corporate_services/advertising.html" rel=""
                              title="Advertising sales">Advertising sales</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/corporate_services/reprints.html" rel=""
                              title="Reprints">Reprints</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/corporate_services/classifiedadinprint.html"
                              rel=""
                              title="Classified Advertising">Classified Advertising</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
               </div>
               <script type="text/javascript">var taxonomies = ["MED00300"];</script>
               </div>
            
            <div class="most-links-box js-marker">
               
               <div class="most-header">
                  
                  <h3>Most</h3>
                  
               </div>
               
               <ul>
                  <li class="most-cur-sel">
                     <h4>Most Read</h4>
                     	  
                     <div class="most-list">
                        	    
                        <ol>
                           <li class="first-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/92/6/443?rss=1&amp;ssource=mfr">Breast Density and Cancer Risk: What Is the Relationship?</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/90/9/713?rss=1&amp;ssource=mfr">The Female Prostate</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/91/14/1194?rss=1&amp;ssource=mfr">Tobacco Smoke Carcinogens and Lung Cancer</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/107/6/djv048?rss=1&amp;ssource=mfr">Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity,
                                 Poverty, and State</a></li>
                           <li class="last-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/105/23/1799?rss=1&amp;ssource=mfr">Elevated Plasma Vitamin B12 Levels as a Marker for Cancer: A Population-Based Cohort Study</a></li>
                        </ol>
                        	    <a href="http://jnci.oxfordjournals.org/reports/mfr1.dtl" class="view-all">» View all Most Read articles</a>
                        	  
                     </div>
                     	
                  </li>
                  <li>
                     <h4>Most Cited</h4>
                     	
                     <div class="most-list">
                        	  
                        <ol>
                           <li class="first-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/92/3/205?rss=1&amp;ssource=mfc">New Guidelines to Evaluate the Response to Treatment in Solid Tumors</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/90/18/1371?rss=1&amp;ssource=mfc">Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/85/5/365?rss=1&amp;ssource=mfc">The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International
                                 Clinical Trials in Oncology</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/82/13/1107?rss=1&amp;ssource=mfc">New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening</a></li>
                           <li class="last-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/82/1/4?rss=1&amp;ssource=mfc">What Is the Evidence That Tumors Are Angiogenesis Dependent?</a></li>
                        </ol>
                        	  <a href="http://jnci.oxfordjournals.org/reports/mfc1.dtl" class="view-all">» View all Most Cited articles</a>
                        	
                     </div>
                     
                  </li>
               </ul>
               
            </div>
            
            
            
         </div>
         
         
         
         <div id="oas_bottom" class="ad_hidden">
            <iframe id="id_advertframe_bottom"
                    src="/resource/htmlfiles/advert.html?p=Bottom&amp;u=jnci.oxfordjournals.org/content/89/11/790.full"
                    width="0"
                    height="0"
                    frameborder="0"
                    scrolling="no"
                    class="resize_ad"></iframe>
            
         </div>
         
         
         
         
         
         
         <div id="secondary_footer">
            
            <div id="issn">Online ISSN 1460-2105 - Print ISSN 0027-8874</div>
            
            
            <div id="copyright"><a href="http://www.oxfordjournals.org/our_journals/terms.html">Copyright ©</a> 
               <span>2015</span> Oxford University Press
               
            </div>
            
         </div>
         
         <div id="primary_footer">
            
            <div id="site_logo">
               <strong><span>Oxford Journals</span></strong>
               <em><span>Oxford University Press</span></em>
               
            </div>
            
            
            <div id="third_nav">
               
               <ul>
                  <li><a href="http://www.oxfordjournals.org/site_map.html">Site Map</a></li>
                  <li><a href="http://www.oxfordjournals.org/legal/privacy_policy.html">Privacy Policy</a></li>
                  <li><a href="http://global.oup.com/cookiepolicy/?siteid=journals">Cookie Policy</a></li>
                  <li><a href="http://www.oxfordjournals.org/legal/legal_notices.html">Legal Notices</a></li>
                  <li><a href="http://www.oxfordjournals.org/faq/">Frequently Asked Questions</a></li>
               </ul>
               
            </div>
            
            
            <div id="other_oup_sites">
               
               <form action="http://www.oxfordjournals.org/service/redirect">
                  <div>
                     <label for="site_list">Other Oxford University Press sites:</label>
                     <select name="url" id="site_list">
                        <option value="http://www.oup.com">Oxford University Press</option>
                        <option value="http://www.oxfordjournals.org/china/">Oxford Journals China</option>
                        <option value="http://www.oxfordjournals.org/japan/">Oxford Journals Japan</option>
                        <option value="http://www.oup.com/uk/academic">Academic &amp; Professional books</option>
                        <option value="http://www.oup.com/oxed">Children's &amp; Schools Books</option>
                        <option value="http://www.oup.com/uk/dictionaries">Dictionaries &amp; Reference</option>
                        <option value="http://www.oup.co.uk/newdnb/">Dictionary of National Biography</option>
                        <option value="http://www.oup.com/uk/digital_reference">Digital Reference</option>
                        <option value="http://www.oup.com/elt/">English Language Teaching</option>
                        <option value="http://www.oup.com/uk/textbooks">Higher Education Textbooks</option>
                        <option value="http://www.oup.co.uk/ieu/">International Education Unit</option>
                        <option value="http://www.oup.com/uk/law">Law</option>
                        <option value="http://www.oup.com/uk/medicine">Medicine</option>
                        <option value="http://www.oup.com/uk/music">Music</option>
                        <option value="http://www.oup.com/online">Online Products &amp; Publishing</option>
                        <option value="http://oxfordbibliographiesonline.com">Oxford Bibliographies Online</option>
                        <option value="http://oxforddictionaries.com">Oxford Dictionaries Online</option>
                        <option value="http://www.oed.com">Oxford English Dictionary</option>
                        <option value="http://www.oxfordlanguagedictionaries.com">Oxford Language Dictionaries Online</option>
                        <option value="http://www.oxfordscholarship.com">Oxford Scholarship Online</option>
                        <option value="http://www.oup.com/uk/reference">Reference</option>
                        <option value="http://www.oup.com/uk/rights">Rights and Permissions</option>
                        <option value="http://www.oup.com/uk/booksellers">Resources for Retailers &amp; Wholesalers</option>
                        <option value="http://www.oup.com/uk/corporate">Resources for the Healthcare Industry</option>
                        <option value="http://www.oup.com/vsi">Very Short Introductions</option>
                        <option value="http://www.oup.com/worldsclassics">World's Classics</option></select>
                     
                     <input type="image" src="/resource/image/buttons/go.gif" alt="Go"
                            class="inline_button" />
                     
                  </div>
               </form>
               
            </div>
            
         </div>
         <script type="text/javascript"
                 src="http://gab.cookie.oup.com/aws-cookie/oup.cookiepolicy.pack.js"
                 defer="defer"></script>
         
         <script defer="defer"
                 src="http://oi-underbar.ifactory.com/underbar/js/jquery-ui.min.js"
                 type="text/javascript"></script>
         <script defer="defer"
                 src="http://oi-underbar.ifactory.com/underbar/js/jcarousellite.js"
                 type="text/javascript"></script>
         <script defer="defer"
                 src="http://oi-underbar.ifactory.com/underbar/js/pf_oiunderbarinit.js"
                 type="text/javascript"></script>
         <script defer="defer" src="/resource/js/underbar_local.js" type="text/javascript"></script>
         <script defer="defer" type="text/javascript">
    function fnc_onDomLoaded() {
        var query_context = getQueryContext();
        PF_initOIUnderbar(query_context,":QS:default","","JRN"); 
        PF_insertOIUnderbar(0);
    };
    if (window.addEventListener) { 
        window.addEventListener('load', fnc_onDomLoaded, false); 
    } else if (window.attachEvent) { 
        window.attachEvent('onload', fnc_onDomLoaded); 
    } 
</script>
         <noscript><img src="//ouptag.scholarlyiq.com/ntpagetag.gif?js=0" height="1" width="1"
                 border="0"
                 hspace="0"
                 vspace="0"
                 alt="" /></noscript><script type="text/javascript" src="//ouptag.scholarlyiq.com/ntpagetag.js"></script><script type="text/javascript">
        var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
        document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
        </script><script type="text/javascript">
        try {
        var pageTracker = _gat._getTracker("UA-189672-16");
        pageTracker._setDomainName(".oxfordjournals.org");
        pageTracker._trackPageview();
        } catch(err) {}
        </script></div>
   </body>
</html>